WO1997022296A1 - System and method for testing the function of the autonomic nervous system - Google Patents

System and method for testing the function of the autonomic nervous system Download PDF

Info

Publication number
WO1997022296A1
WO1997022296A1 PCT/CN1995/000097 CN9500097W WO9722296A1 WO 1997022296 A1 WO1997022296 A1 WO 1997022296A1 CN 9500097 W CN9500097 W CN 9500097W WO 9722296 A1 WO9722296 A1 WO 9722296A1
Authority
WO
WIPO (PCT)
Prior art keywords
signal
sympathetic
wave
ecg
nervous system
Prior art date
Application number
PCT/CN1995/000097
Other languages
French (fr)
Chinese (zh)
Inventor
Xiangsheng Wang
Original Assignee
Xiangsheng Wang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xiangsheng Wang filed Critical Xiangsheng Wang
Priority to PCT/CN1995/000097 priority Critical patent/WO1997022296A1/en
Priority to AU42519/96A priority patent/AU4251996A/en
Publication of WO1997022296A1 publication Critical patent/WO1997022296A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/40Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4029Detecting, measuring or recording for evaluating the nervous system for evaluating the peripheral nervous systems
    • A61B5/4035Evaluating the autonomic nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/318Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346Analysis of electrocardiograms
    • A61B5/349Detecting specific parameters of the electrocardiograph cycle
    • A61B5/352Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval

Definitions

  • the present invention relates to a sputum and method for testing human cerebral pedigrees, and more particularly to a function for sympathetic and sympathetic nerves by spectral analysis of heart rate variability The method of detecting and analyzing the status of the sympathetic and sympathetic nerves.
  • the sympathetic nerve center located in the medulla oblongata and the sympathetic side of the fr'iM and its nerve fibers directly control the activity state of the cardiovascular system and some involuntary S officials.
  • patients with excessive sympathetic excitability may have symptoms such as rapid heartbeat, '-sweeing sweat, I diarrhea, facial flushing, and emotional irritability; and those who pay too much sympathetic excitability often have the opposite Braided.
  • 3 ⁇ 4 fx change it subjectively determined to be autonomous species of dysmenorrhea (called autonomic H).
  • autonomic H autonomous species of dysmenorrhea
  • the sympathetic or sympathetic nerves is it strong? It is only by pushing it. This makes the break period prolonged, the cost of the break is expensive, and this is in his: 'Go base ⁇ :[;_ ⁇ ⁇ ' ⁇ - out; t break.
  • People ⁇ ] have realized that the speed of the human heart beating is controlled by the excitability of the sympathetic and sympathetic chanting. Sympathetic nerve excitability, will lead to 'speed faster: and even sympathetic nerve excitability, it will lead to slowing of heart rate. Therefore, the heart rate can be used as a window to detect and judge the functional state of the sympathetic and sympathetic nerves.
  • Heart Rate Variability has become a target of great attention and research.
  • the variability of heart rate (HR V ) is thought to be related to the physiological and rational state of the heart, and is a manifestation of the anti-FL ⁇ ⁇ and the heart disease of the cardiovascular system for internal and external environmental changes. Therefore, the analysis of heart rate variability, especially the analysis techniques developed in recent years, is to evaluate the physiological and pathological state of cardiovascular system, especially
  • the purpose of the present invention is to provide a system and method capable of non-invasively measuring the persuasive state of the human nervous system, and completely changing the complexity of the prior art by complexizing each of the 3 ⁇ 4 3 ⁇ 4 A method of performing exclusion and extrapolation for diagnosis is detected.
  • a system and method for detecting an anesthetic power system by collecting an electrocardiographic signal and analyzing heart rate variability includes an ECG signal storage ⁇ , 4!
  • the electrocardiogram of the subject collected in a certain period of time is stored in the storage I ⁇ , the storage S can be portable or single-chip type, it It may be provided with an infrared emission ⁇ for outputting the stored ECG signal.
  • the system may further comprise an infrared for receiving and passing through the interface circuit, the output ECG signal being sent to the computer for processing Receiver; a microcomputer for performing a perceptual analysis of the ECG signal to obtain a qualitative report of the subject's confession and sympathetic nerves: an output device for printing Test the results of the tiller.
  • the system of the present invention also provides a speech unit and a speaker that can guide the movement of the subject, adjust the different body position, and collect the ECG signal in the state of the sympathetic and/or the sympathetic nervous system. .
  • the basic principle of the present invention is to utilize the difference in body position and respiratory state on the one hand, and the different effects of drugs (not to be administered, administered, and give different drugs) on the other hand, respectively, and to pay sympathetic and I or pay Sympathetic nervous system for stimulation, detection of ⁇ '] heart rate degeneration before and after stimulating - use this window to conduct a table! To analyze the signal control theory, so that you can get sympathetic sympathetic nervous system and pay sympathy The interaction of the system and the conclusion of the functional state.
  • heart rate variability is analyzed using spectral analysis.
  • the first is to extract each R-R interval from the original ECG signal to form an R-R interval sequence.
  • an interval sequence is used, the amplitude value is equal to the R-R interval value, and ⁇ L can be sampled by interpolation method into time interval such as f'r. It has been shown that these two methods are equivalent.
  • % processing can be performed by filtering, interpolation, and the like.
  • ⁇ Quasi-random heart rate variability signal usually approximated as a stationary random over, can be seen as a single density - No white noise W ( n ) excitation of a certain - impulse L is h ( n )
  • Sw, S x are the persuasion rate of input and output respectively
  • H is the frequency characteristic or transfer function of the system. Therefore, it is known that the ruler H(Z) can find the random signal ⁇ Sx(e).
  • (Z) is the parametric model of the random signal.
  • the present invention employs an autoregressive (eight model (referred to as an all-pole model) whose expression is as follows:
  • M is the order of the AR model and can be determined according to certain criteria, such as the MC or FPE criteria and the nature of the it.
  • the parameter a (k) of the AR mode S1 and the white noise spectral density No can be obtained, and then the density of the persuasion rate can be estimated by the following formula:
  • f(t) is used to find the maximum absolute value PK and the two R-R intervals.
  • Count f (t) sequentially. Find the point of PK(n) > (n) and determine whether it is the R wave and the R wave position.
  • the adaptive recursion of the threshold is:
  • the autoregressive (AR) model estimates are performed for each segment of the signal to obtain the AR shuttle parameters.
  • the estimation of the parameters of the AR model includes the estimation of the model coefficients ⁇ , - ⁇ , the estimation of the white noise 'S ⁇ No, and the estimation of the order M of the model, from the time domain to
  • the invention changes the existing means for persuasing the idiopathic physiology of the plant, so that the methods of using the heart rate variability (HRV) for academic use have been studied and clinically completed, and the heart rate variability is once ( HRV) advised the Xin method of language to persuade use -
  • HRV heart rate variability
  • the invention can not only understand the super-potential of heart rate change, but also distinguish the interaction between a certain intersection, the 3 ⁇ 4 nerve and the sympathetic nerve, and change the prior art using the non-inference method of j, and rely on the detection to judge that it is sympathetic Still paying.
  • FIG. 1 is a schematic representation of a plant neurological functional test system according to the invention.
  • 2 is a schematic illustration of one embodiment of a testing process for a system and method in accordance with the present invention.
  • Fig. 3 is a flow chart of a soft gram running in the autonomic nervous system function test system according to the present invention.
  • FIG. 5 is a schematic schematic diagram of the mid-infrared receiver of the system shown in FIG. 1.
  • Figure 6 is a curve in the supine position of the recumbent (i.e., in the sacral section of Figure 2):
  • Figure 7 is a curve in the controlled position of the supine position (i.e., in the B segment of the figure); It is a curve in the standing free breathing state (ie, in the C segment of Figure 2);
  • Figure 9 is the curve in the standing position controlled breathing (ie, in the D segment of Figure 2);
  • 13- 1, 8 is a comparison of the time-domain X-signal and ⁇ -de-dc component of each segment corresponding to Fig. 6 -...12 and the signal of the frequency-sense rate signal S after the AR model transformation ⁇ :
  • FIG. 1 3 is a comparison chart of the X ⁇ ⁇ and the persuasion s signal s in the squat section of the squat free breathing in the experiment compared with the E 6:
  • Figure 14 is a comparison diagram of the X signal and the S signal corresponding to the B segment shown in Figure 7:
  • Figure 15 is a comparison diagram of the X signal and the S signal corresponding to the C segment shown in Figure 8:
  • Figure 16 is the same as Figure 9
  • Fig. 17 is a view showing an X signal and an S signal corresponding to the E segment shown in Fig. 10:
  • Fig. 18 is a F segment shown in Fig. 11
  • Fig. 19 is a three-dimensional graph of four curves A, B, C, and D made by the segment state as the Z axis.
  • Figure 20 is a three-dimensional graph of six curves A, B, C, D, E, and F made with the segmentation state as the Z axis.
  • Fig. 21 is a diagram showing an example of a quantitative conclusion report on the effect of body position on plant persuasion after the calculation of the pedigree analysis in accordance with the present invention.
  • Fig. 22 is a diagram showing an example of a quantitative conclusion report on the effects of the function of the respiratory sputum plant after the analysis of the sputum analysis in accordance with the present invention.
  • FIG. 1 there is shown the principle of perennial, experimental, and f-systems according to the present invention.
  • a single-chip ECG signal acquisition and storage device i 0 is included, and the ECG under different posture states and the same breathing state (Fig. 2) is collected from the subject by a certain ECG lead.
  • the signal is stored in the ECG storage; 11 within. @4 shows the electrical principle H of the ECG signal memory, where: U is the central processing; ⁇ CPU, U2 is, read and store iROM, U3 is the address buffer, U4 is the random memory W ⁇ AM.Uo For analog-to-digital conversion ⁇ !: A/1, U6 is the line driver ⁇ , L; 7 is the binary input into the NOR gate.
  • U8 is the ECG signal amplified by four operational amplifiers.
  • ULEAD is the ECG signal input terminal. .
  • the ECG signal collected through this end passes through the ECG amplifier, and is sent to the A/D converter ⁇ 5, sent to the CPU (U1) for processing, and stored in the random storage S (RAM M and 'port, read and save Storage: (ROM) U2.
  • a 15-minute ECG signal is acquired and stored.
  • LS 2 because the supine ⁇ position and the controlled breathing faster than the free-style breathing rate are separately stimulating: Concealed nerves. Standing and free breathing stimulate the sympathetic nerves, respectively.
  • the present invention-Hf 15 minutes is divided into four stages of different sympathetic and/or paying, and the 3 ⁇ 4 nervous system is stimulated differently: in the first period of time A, the person who is a long time takes a flat sleep ⁇ (stimulation) Pay Sensory nerve) free breathing (stimulation of sympathetic nerves); in the second period of time B, the subject's position is still supine (stimulation pays the nerve), but changed to controlled breathing, that is, given a fast by the speech unit Exercising under the guidance of free-breathing beats (stimulation and sympathetic nerves): In the third period of time C, the subject's position changed from supine to standing (stimulating sympathetic nerves), free-style breathing (stimulating sympathetic nerves) The fourth period of time D is the controlled breathing of the subject (stimulation of sympathetic nerves) (stimulation of sympathetic nerves).
  • the segment is 3 minutes: the ⁇ segment is 4 minutes: the C segment is 4 minutes and the signal in the first minute is the signal during the change from the supine position to the standing position. Special treatment; D segment is also 4 minutes.
  • the stored electrocardiographic signal is transmitted to the microcomputer 23 via an infrared emission ⁇ 12 (see Fig. 1).
  • the microcomputer 23 is connected to the infrared receiver 21 via the interface 22, and further receives the electrocardiographic signals (tX, G) received by the infrared receiver 21.
  • FIG 5 shows the principle S of an infrared receiver 21 that can be used in the system of the present invention.
  • the signal received by the infrared receiving tube D1 is operated and amplified by the operational amplifier IC1, and is compared by the comparison of !!!: IC2 is inverted by the phase If IC3, and then output by the line cloud force ⁇ 1C, which is output.
  • S], S2, and S3 are sockets.
  • the signal transmission at this time can be used to connect the driver chip to the string of the microcomputer ( ⁇ communication interface.
  • the language unit and the speaker can also be combined with the finger-type ECG signal set and storage device 10.
  • the microcomputer 23 may include a voice card, a multifunction card, a display card hard disk, a floppy disk drive, a main board, a power source, and the like. 24 also has an output device for analysis and hooking the S signal when in the different sections of the city and urban signal X (see FIG. (! - FIG. 22) ⁇
  • Figure 3 shows the software processing of the ECG i number, the persuasion analysis, and the quantitative results of the neural and sympathetic neural system.
  • the obtained R-R interval time domain signal is divided into Jt and preprocessed in step S13. That is, according to the segment shown in Fig. 2 (A, B, C, D and the E-station representing the entire supine position and the F-segment representing the entire standing position), the obtained R-R interval time signal (R wave) The sequence signal is intercepted and processed.
  • the R-wave signal that is divided in each segment is called the X signal, which is the segmented R-R interval time domain signal.
  • Figures 16-18 are R-R interval waveforms recorded in a control experiment performed when no drug was administered to the subject.
  • Figure 18 is the entire R-R interval waveform
  • Figure 16-7] is the R-R interval waveform of A, B, C, D, h;
  • represents an unadministered experiment.
  • ⁇ 17 f indicates "XB1200 ⁇ " indicates that the curve is a squat section, ie, a flat squat, a control h'n, and a table gives 3 ⁇ 4 ⁇ ⁇ ).
  • the " ⁇ 1200 ⁇ " marked in the middle represents the song as li rt -'pf 1. Uncontrolled squatting experiment of supine free breathing plus controlled breathing, etc.
  • step S21 After the above analysis processing is performed on the R--R interval, the processing proceeds from step S21.
  • the regression (AR) model is used for ⁇ estimation.
  • Sw S are the persuasion rates of the input and output, respectively, and H is the frequency-semi-characteristic or transfer function of the system.
  • H(Z) is known, and the random signal is good for SxW', and H (Z) is a parametric model of random apostrophes.
  • the autoregressive (AR) model nicknames the all-pole model, and its expression is as follows:
  • f is the o frequency (Hz) and At is the sampling interval.
  • the estimation of the AR model parameters includes: model parameters. ., ⁇ ⁇ ⁇ Density No . and ' ⁇ 3 ⁇ 4! Order M
  • the method of counting is not one or one, here?
  • the program used in the program is not one or one, here?
  • the sum of the front and back prediction errors e, is the minimum
  • R M is required , and the method of linear algebra can be used to find the AR mode parameter from (9).
  • the calculation amount is large, and the Hermit and the anti-Ermite characteristics of the R M matrix are used here to derive.
  • Equation (20) has the same form as the Levinson iteration, from which the AR ⁇ parameter and the white noise spectral density No can be obtained.
  • model order M Another key issue in model parameter estimation is the choice of model order M, which is an important but unresolved problem. If the order is too low, what is the estimated estimate? The peaks of existence are blurred; the order is too high, and false details are produced. In the procedure of the present invention, the inventors have repeatedly tested, calculated, compared, and concluded that the order of the information theory criterion can be satisfied between the 11th and 19th steps, and the result of 7 A is obtained.
  • the criterion of the information theory referred to herein is : d (M+l)
  • f is the frequency (Hz) and At is the sampling interval.
  • 13 to 18 show the ratios of the X signal waveforms of an unadministered control experiment and the corresponding S signal curves of the respective segments obtained after the above AR model transformation.
  • 13 is the work half density corresponding to the stage A of the subject's free breathing
  • FIG. 14 is the density of the persuasion rate corresponding to the stage B of the subject's controlled position breathing
  • FIG. 15 corresponds to The persuasion rate of the stage C in which the subject takes a free breathing
  • 3 ⁇ 4 16 is the persuasion rate corresponding to the stage D of the subject taking controlled breathing
  • Figure 17 is the subject.
  • Figure 18 is the stage corresponding to the free breathing and controlled call of the standing type.
  • step S23 each feature value is calculated based on the above-described rate ⁇ density result.
  • a conclusion report as shown in Fig. 21 and 22 is given for the doctor to use as a basis for diagnosis.
  • the meanings of the symbols used in the tables and in the various curves are as follows:
  • VAR1 (sometimes labeled V) - R-R interval mean square error (ms 2 )
  • the present invention also makes the segmentation rate as a Z-axis by segmentation? If density comparison chart.
  • the excitability of the sympathetic and sympathetic nerves under various stimuli can be clearly and intuitively observed.
  • the first set of peaks of the curve shows the total activity of the sympathetic and sympathetic nerves
  • the second set of peaks is the intensity of the sympathetic nerves when excited alone. This provides the doctor with a direct report and report on the patient's autonomic sensational state and the sympathetic and sympathetic interactions.
  • the above various processing devices and processes can be performed by a computer software program, and in the present invention, an application software that is particularly suitable for use in the plant neuron stimulation test system of the present invention is provided.
  • Experiment 2 Injecting atropine to stimulate the excitability of the sympathetic system: Experiment 3: Taking propranolol to stimulate the sympathetic nervous system
  • Table 1 shows the statistical results of the effects of postural motion and drug on R-R interval variability in 20 trials.
  • the meanings of the alphabetic symbols used here and / in the continuation table are the same as those mentioned above.
  • the asterisk before the asterisk indicates the ratio of A/B, C/D (free breathing zone / controlled breathing zone) 4i: the triangle after the data indicates the second (administration of atropine), the first 3 (administration of Xinde Ning) ⁇ 4 (simultaneous administration of atropine and Xin De Ning) and the ratio of the control experiment K not administered) 4.
  • One of the asterisks "'” indicates P ⁇ 0.05: two stars No. ' ⁇ :' - "Expression I) 0.01: Three, asterisk "* -X" means P ⁇ 0.001, which indicates significant specificity.
  • the center frequency of the high frequency component is consistent with the respiratory rate.
  • the effect of ' ⁇ free breathing and controlled breathing (20 times / min, ie 0.33 Hz) on heart rate ⁇ was compared.
  • the controlled breathing causes the center frequency of the high frequency component to be 0.22 ⁇
  • the study of heart rate under drug conditions is to confirm the specificity of the heart rate spectrum, the reflection of the systemic activity of the 3 ⁇ 4 nerves, the sympathetic sympathetic system, and the sensitivity of this analysis method to changes in sympathetic and sympathetic activities.
  • heart rate spectrum changes far more than ⁇ tachycardia Therefore, through the study of heart rate ⁇ , it provides an effective means for the classification of clinical diagnosis, the prediction of disease and the observation of curative effect, especially the evaluation of the autonomic nervous system of patients with heart disease.

Abstract

A system and method for testing the function of the autonomic nervous system of human body is disclosed. The method comprises the following steps: stimulating the sympathetic nervous system or the parasympathetic nervous system; analysing the R wave of ECG signal sectionally according to different stimulating; analysing it's power spectrum using Auto-Regressive (AR) model so as to obtain the quantitative analysing result of the intensity difference of the excitability between the sympathetic nervous system and the parasympathetic nervous system of the tested body.

Description

植物神经系统功能测试系统及其方法  Autonomic nervous system function test system and method thereof
. 术领域 . Field of surgery
本发明涉及一种对人体植物神经糸统劝能进行测试的糸统及其 方法,更具体地,涉及一种用于通过对心率变异性进行谱分析,进而 对交感神经和付交感神经的功能状况进行检測的糸统,以及吋交感 神经和付交感神经的功能状况进行检测和分析的方法。  The present invention relates to a sputum and method for testing human cerebral pedigrees, and more particularly to a function for sympathetic and sympathetic nerves by spectral analysis of heart rate variability The method of detecting and analyzing the status of the sympathetic and sympathetic nerves.
背景技术 Background technique
在人的身体之中,包括交感神经和付交感神经组成的植物神经 ? t ,有如自云力控制糸统中之控制 ,控制着人体内部生理和生化活 -f) ,调整不随意 S官的活动,进而达到身体的内 卜环境的平衡。 所以 吋植物神经 统劝能的检測是吋人休的心血管糸统的活动、乃至对 ±刊植物祌经 统控制的全身内脏器官兴备性强弱进行评价和 i 断 的重要内 。  Among the human body, including the sympathetic nerves and the sympathetic nerves of the autonomic nerves? t, like the control in the cloud control system, control the internal physiological and biochemical activities of the human body -f), adjust the activities of the involuntary S official, and then achieve the balance of the internal environment of the body. Therefore, the detection of 吋 吋 神经 劝 劝 劝 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸 糸
在人休这羊一个控制糸统中,位于延髓的付交感神经中枢和在 fr'iM旁的交感¾及其神经纤维直接控制着心血管系统和一些不随意 S官的活动状态。一般说来,交感神经兴奋性过强的病人会出现心跳 加快、 ' -慌盗汗、 I泻、脸潮红、情绪烦踔等症状;而付交感神经兴奋 性过强的 人,则往往出现相反的 ώ状。但是,到目前为止,在医学界 还没有找到一种方法或仪 ,能够直接对交感神经和什交感神经 ύ '} 劝能状态 .即兴奋性强弱,进行定性乃至定量的分析和測量。 a为除 7在实验室中做动物实验以外,不可能仅为了测试 u的而手 切开 ' 7式者的交感及付交感神经对其进行检測。目前所能够敉到的,是根 据上述机理,靠医生询问被怀疑患有植物神经系统劝能紊乱的 人 的主诉,然 让 ^人去做各 ^官糸统的全面检鱼。当措除了各脏器的 In the control system of the human resting sheep, the sympathetic nerve center located in the medulla oblongata and the sympathetic side of the fr'iM and its nerve fibers directly control the activity state of the cardiovascular system and some involuntary S officials. In general, patients with excessive sympathetic excitability may have symptoms such as rapid heartbeat, '-sweeing sweat, I diarrhea, facial flushing, and emotional irritability; and those who pay too much sympathetic excitability often have the opposite Braided. However, so far, there has not been a method or instrument in the medical field that can directly analyze and measure the sympathetic and sympathetic nerves, ie, the excitability, qualitative and quantitative analysis. a is a laboratory experiment in addition to 7 in the laboratory, it is impossible to test the u's sympathetic and sympathetic nerves. What is currently available is based on the above-mentioned mechanism, relying on doctors to ask the person who is suspected of having an autonomic nervous system to persuade the disorder, and then let the person to do a comprehensive inspection of the various bureaucratic fish. When it comes to removing all organs
¾ f x性改变之 , it主观认定是自主种经糸统紊乱( 称为植物神经 H ) . 而至于是交感神经还是付交感神经兴备性强,则?、靠推 Ά而已 . 这使 断 Ά期延长、 i 断费用 f?贵 ,而且这种在 他:'去的基 <·:[;_± ί'ι-出的; t断 .其准 半也是不理想的 ,, 人 ίί]已经认识到 ,人体心脏跳动的快慢受到交感神经和付交感 祌经的兴奋性的控制。 交感神经兴奋性强,会导致' 速度加快:而 什交感神经兴奋性强,则会导致心跳速度的减慢。所以可以通过心跳 速度作为一个窗口,对交感神经和付交感神经的功能状态进疔检测 和判断。 特別是近年来,心率的变导性( Heart Rate Variability (HRV) ) 趟来越成为人们所重视和研究的目标。 心率的变异性(HR V )被认为 与心脏的生理和^理状态有关,是心血管 统对内、外环境变化的反 FL χλ及吋心脏疾病的一个表现。 因此,心率变异性的分析、特别是近 年来发展的诸分析技术,为评价心血管糸统的生理、病理状态,尤其3⁄4 fx change, it subjectively determined to be autonomous species of dysmenorrhea (called autonomic H). As for the sympathetic or sympathetic nerves, is it strong? It is only by pushing it. This makes the break period prolonged, the cost of the break is expensive, and this is in his: 'Go base <·:[;_± ί'ι- out; t break. Not ideal, People ίί] have realized that the speed of the human heart beating is controlled by the excitability of the sympathetic and sympathetic chanting. Sympathetic nerve excitability, will lead to 'speed faster: and even sympathetic nerve excitability, it will lead to slowing of heart rate. Therefore, the heart rate can be used as a window to detect and judge the functional state of the sympathetic and sympathetic nerves. In particular, in recent years, Heart Rate Variability (HRV) has become a target of great attention and research. The variability of heart rate (HR V ) is thought to be related to the physiological and rational state of the heart, and is a manifestation of the anti-FL χ λ and the heart disease of the cardiovascular system for internal and external environmental changes. Therefore, the analysis of heart rate variability, especially the analysis techniques developed in recent years, is to evaluate the physiological and pathological state of cardiovascular system, especially
;1心血管自主祌经系统功能,提供了一种无创的研究方法和重要的 量指标。 ;1 cardiovascular independent chanting system function, providing a non-invasive research method and important quantitative indicators.
早期在实验室中对心率变异性的分析主要采用统计学的方法, 如 Κ一 R间期的均值和标准差、各种长度 —R间期出现的领度直万 L¾等 这些方法可以鉴别自主神经活动总的变化,但不能区分交感和 f| 神 ϊ 之间的相互作用情 ¾。 因此,近年来,人们义发展为采用 f]率 分忻方法,包括快速傅立叶变换( FFT )法、周期图和自回归模 ¾的 1#估计方法。由于对于短时数据,自回归模型法能得到的頻率分 辩率比经曲的 FFT和周期图法有更好的估计效果, Θ此现在更多地 用自 回归模型法进行心率变异性的劝率 分析。 但是这种研究也 都 、 ί亭留在学术讨论的水平,还没有一种根据心率变异性 #分析来 Early analysis of heart rate variability in the laboratory mainly used statistical methods, such as the mean and standard deviation of the R-interval, the length of each interval - the interval between the R-intervals, L3, and other methods can identify autonomy. The total change in neural activity, but can not distinguish between sympathetic and f| Therefore, in recent years, people have developed a method of using the f] rate bifurcation method, including the fast Fourier transform (FFT) method, the periodogram, and the autoregressive mode 1# estimation method. Since the frequency resolution obtained by the autoregressive model method has a better estimation effect than the FFT and the periodogram method for the short-term data, the autoregressive model method is now used to increase the rate of heart rate variability. analysis. However, this kind of research is also at the level of academic discussion, and there is no one based on heart rate variability #analysis
\k 值物神经糸统功能的仪器设备被制作出来用于医学临床之中\k Value equipment for neurological function is made for medical use
11明内 ¾: 11 Ming 3⁄4:
a此.本发明的目的在于,提供一种能够无创伤地测 χΚ人 ί本植物 神经 统劝能状态的糸统和方法,彻底改变现有技术中通过对各生 ¾ ¾进行繁锁复杂的检測进行排除和推断来进行诊断的方法。  The purpose of the present invention is to provide a system and method capable of non-invasively measuring the persuasive state of the human nervous system, and completely changing the complexity of the prior art by complexizing each of the 3⁄4 3⁄4 A method of performing exclusion and extrapolation for diagnosis is detected.
本发明进一步的目的在于.提供一 完整的植物神经糸统劝能 ^ ^设 它能够通过吋受试者心率变化趋势的测试,而区分受^者 ,¾祌 与什交感神经之间的相互作用 .并且能够給出交 ,%祌经和 ί十 ν; 神½中哪一个兴奋性强,以及强 Ψ少的定性及定量的 i 断数 本发明再进一步的目的在于,提供一套能够在植物神经系统功 能测试系统中运行、通过对心率变异性的測试数据进行分析处理、而 作出受试者交感神经与付交感神经之间的相互作用、劝能状态的定 量性结论的软件。 It is a further object of the present invention to provide a complete autonomic nervous system that allows it to distinguish between the recipient, the interaction between the 3⁄4祌 and the sympathetic nerve, by testing the heart rate of the subject. And can give the intersection, % 祌 and ί 十ν; which one of the gods is excitatory, and the qualitative and quantitative i-break number It is still a further object of the present invention to provide a set of mutual sympathetic and sympathetic nerves between a subject capable of operating in a plant nervous system function test system and analyzing and processing test data of heart rate variability. Software that acts to persuade the quantitative conclusions of the state.
根据本发明,提供了一种通过吋心电信号的采集以及对心率变 异性进行分析进而检測植物神经系统劝能的糸统和方法。 本发明 统包括一个心电信号存贮^,4!在一定时间内所采集到的受试者的 心电图存贮于该存贮 I ^内,这个存贮 S可以是便携式或单片机式的, 它可以带有一个红外发射 ^,用于输出所存贮的心电信号,相应地, 该系统还可以包括一个用于接收并通过接口电路, 所述输出的心 电信号送入计算机进行处理的红外接收器;一个微计算机,用于对心 电信号进行劝率谱分析,以得出对受试者交惑神经和付交感神经 ¾的进行測试后的定性报告:一个输出装置,用于打印出检测分忻结 果。同时本发明的糸统还提供有指导受试者动作、调整不同体位状志 便在吋交感和 /或付交感神经 统进行所需要的刺激的状态下采 集心电信号的语音单元和杨声器。  According to the present invention, there is provided a system and method for detecting an anesthetic power system by collecting an electrocardiographic signal and analyzing heart rate variability. The invention includes an ECG signal storage ^, 4! The electrocardiogram of the subject collected in a certain period of time is stored in the storage I ^, the storage S can be portable or single-chip type, it It may be provided with an infrared emission ^ for outputting the stored ECG signal. Accordingly, the system may further comprise an infrared for receiving and passing through the interface circuit, the output ECG signal being sent to the computer for processing Receiver; a microcomputer for performing a perceptual analysis of the ECG signal to obtain a qualitative report of the subject's confession and sympathetic nerves: an output device for printing Test the results of the tiller. At the same time, the system of the present invention also provides a speech unit and a speaker that can guide the movement of the subject, adjust the different body position, and collect the ECG signal in the state of the sympathetic and/or the sympathetic nervous system. .
本发明的基本原理是,一方面利用体位和呼吸状态的不同、另一 方面利用药物(不给药、给药、给不同的药)的不同作用,分别对交感 神 i糸统和 I或付交感神经糸统进行刺激,检测 Φ']激前后的心率变 性 -刊用这个窗口,进行一桌列 !要论及的信号控制理分析,从而得 ύ'人沐中交感神经糸统和付交感祌经系统的互相作用及功能状态的 ^断结论。  The basic principle of the present invention is to utilize the difference in body position and respiratory state on the one hand, and the different effects of drugs (not to be administered, administered, and give different drugs) on the other hand, respectively, and to pay sympathetic and I or pay Sympathetic nervous system for stimulation, detection of Φ'] heart rate degeneration before and after stimulating - use this window to conduct a table! To analyze the signal control theory, so that you can get sympathetic sympathetic nervous system and pay sympathy The interaction of the system and the conclusion of the functional state.
根据本发明,利用谱分析法来分析心率变异性。首先就是从原始 的 ECG信号中提取每一个 R— R间期,组成 R— R间期序列。通常采 一等间隔序列,其幅度值等于 R— R间期值, <L可以采用插值法进 f'r等时间间隔采样。曾有人 明这两种方法是等效的,对于偶然的涌J■ H .早搏和其它千扰,可通过滤波、插值等办法进行 %处理。  According to the present invention, heart rate variability is analyzed using spectral analysis. The first is to extract each R-R interval from the original ECG signal to form an R-R interval sequence. Usually, an interval sequence is used, the amplitude value is equal to the R-R interval value, and <L can be sampled by interpolation method into time interval such as f'r. It has been shown that these two methods are equivalent. For accidental surges, premature beats and other disturbances, % processing can be performed by filtering, interpolation, and the like.
吋准随机的心率变异性信号,通常可近似认为是一平稳随机过 , 此,可以看成由 1 密度 -- No的白噪声 W ( n )激励某一-沖激响 L 为 h ( n )的线性束统所产生: η = wn * 其中 h"为总激响应, *为卷积, W,、为白噪声。 吋Quasi-random heart rate variability signal, usually approximated as a stationary random over, can be seen as a single density - No white noise W ( n ) excitation of a certain - impulse L is h ( n ) The linear beam system produces: η = w n * Where h" is the total excitation response, * is convolution, W, and is white noise.
则 Z=e^ Then Z=e^
其中 Sw,Sx分别为输入和输出的劝率镨, H是系统的频率特性或传 递函数,因此,尺要 H(Z)可知,随机信号的劝率镨 Sx(e )便可求。 HAmong them, Sw, S x are the persuasion rate of input and output respectively, H is the frequency characteristic or transfer function of the system. Therefore, it is known that the ruler H(Z) can find the random signal 镨Sx(e). H
(Z)即是随机信号的参数模型。本发明采用的是自回归(八 模型(义 称全极点模型),其表达式如下: (Z) is the parametric model of the random signal. The present invention employs an autoregressive (eight model (referred to as an all-pole model) whose expression is as follows:
M  M
X(n) = -∑ a(k)X(n-k)+W(n)  X(n) = -∑ a(k)X(n-k)+W(n)
k-1  K-1
X(Z) 1 X(Z) 1
二 H(Z) = ―  Two H(Z) = ―
W(Z) 1 ∑ a(k)Z  W(Z) 1 ∑ a(k)Z
k=l  k=l
其中 M为 AR模型阶次,可根据某些准则,如 MC或 FPE准则及 it, 号性质来确定。 通过模型参数估计算法,即可求得 AR模 S1的参数 a (k),及白噪声谱密度 No,于是可以通过下式估计劝率语的密度: Where M is the order of the AR model and can be determined according to certain criteria, such as the MC or FPE criteria and the nature of the it. Through the model parameter estimation algorithm, the parameter a (k) of the AR mode S1 and the white noise spectral density No can be obtained, and then the density of the persuasion rate can be estimated by the following formula:
Sx(f) = NoAt/|l+ ∑ aM k eXp(-j2 nf At) 利用本发明的糸统和方法,在一定时间内,采集和记录受认者不 同的姿式(平卧和站立)以及不同的呼吸状态(自由呼吸和受控呼吸) 下的连续变化的心电信号(ECG)。首先对这些 ECG信号进行 K波的 >川,采用自适应判据,用一阶导数来识別 R波,找出 R 1»]期 .从 而给出 R波序列信号。 吋 ECG信号进行预处理采用低通差分..求 Γ)'· ECG的一阶导数,其公式为: Sx(f) = NoAt/|l+ ∑ a M k eXp(-j2 nf At) Using the system and method of the present invention, collecting and recording different poses (flat and standing) of the recognized person within a certain period of time And continuously changing ECG signals (ECG) under different respiratory states (free breathing and controlled breathing). First, the K-waves of these ECG signals are used. The adaptive criterion is used to identify the R-waves with the first derivative and find the R 1»] period, thus giving the R-wave sequence signal.吋ECG signal is preprocessed using low-pass differential.. Γ)·· The first derivative of ECG, the formula is:
d(t -=ECG(t)-ECG(t-4)  d(t -=ECG(t)-ECG(t-4)
.¾ 进行一阶低通 波,其经低通?t-波的一阶导数为: .3⁄4 Perform a first-order low-pass wave that is low-passed? The first derivative of the t-wave is:
替换页 (细则第 26糸) Replacement page (Article 26)
〈 经过一段时间(例如 5秒)的心电图自学习 .即对受试者的一般 < After a period of time (for example, 5 seconds), the ECG self-learning
1£CG进行学习和适应之后,吋上述 f(t)找出最大绝吋值 PK及两 、 R— R间隔。例如^ Η0(ϋ) = 0.7 ·χ· PK作为识別 R波的阈值、两 R— R的平均值作为平均 R— R间 1V¾(RRAV)的 始值。順序地计 f (t).找出 PK(n)〉 (n)的点,并且判定其是否 R波及 R波位置。 这 里,阈值的自适应递归为: After learning and adapting for £ CG, the above-mentioned f(t) is used to find the maximum absolute value PK and the two R-R intervals. For example, ^ Η 0 (ϋ) = 0.7 · χ · PK is used as the threshold for identifying the R wave and the average of the two R - R as the initial value of 1V3⁄4 (RRAV) between the average R-R. Count f (t) sequentially. Find the point of PK(n) > (n) and determine whether it is the R wave and the R wave position. Here, the adaptive recursion of the threshold is:
0.3 * (0.7 * Ρ (η)) 0.7 * ΡΚ(η)<1.5 * Ηο(π) 0.1 * (0.7 * Ρ (η)) Q.7 * ΡΚ (π)>1· 5 * Ηο(π) (") + 0.2 * KJiAV(n) 1.5*KR.4V(»)>H-K>0.5 KKAV(n)  0.3 * (0.7 * Ρ (η)) 0.7 * ΡΚ(η)<1.5 * Ηο(π) 0.1 * (0.7 * Ρ (η)) Q.7 * ΡΚ (π)>1· 5 * Ηο(π) (") + 0.2 * KJiAV(n) 1.5*KR.4V(»)>HK>0.5 KKAV(n)
其它 other
itAV ("十 ' itAV ("ten"
经过以上预处理并根据上述体位及呼吸状志的不同,对信号进 行分役。 吋于每段信号进行自回归( AR )模型诸估计,以求 AR梭 ¾!参数。对 AR模型参数的估计包括模型系数 ο,—α^的估计、白噪 'S^ No的估计,以及模型的阶次 M的估计,从时域中变换到  After the above pretreatment and according to the above body position and respiratory status, the signals are divided. The autoregressive (AR) model estimates are performed for each segment of the signal to obtain the AR shuttle parameters. The estimation of the parameters of the AR model includes the estimation of the model coefficients ο, -α^, the estimation of the white noise 'S^No, and the estimation of the order M of the model, from the time domain to
,"求得各段被測 ECG信号的劝率 1#,找出各特征值, ¾终^:过¾ [ f"学理论分析,得出吋不同状态下交感神 & 1 及付交惑神经 统兴奋 性状况的比较和结论。 "Get the persuasion rate of the measured ECG signals in each segment 1#, find out the characteristic values, 3⁄4 final ^: over 3⁄4 [f" theoretical analysis, and get the sympathetic god & 1 and pay confession in different states Comparison and conclusion of the excitatory situation.
本发明改变了现有的对植物神经 统劝能测 i式的手段,使学术 上迄 为止利用心率变异性( HR V )的功率诸方法与临床研完 ¾结 ^, 一次将心率变异性 ( HRV )劝率语分忻方法成劝地运用 ?-|临 /ί 上吋植物祌经 k、统劝能的测 i 之中 为植物神经 统劝能的测 ; 提 ^ 7 加直接和准确的手段 , The invention changes the existing means for persuasing the idiopathic physiology of the plant, so that the methods of using the heart rate variability (HRV) for academic use have been studied and clinically completed, and the heart rate variability is once ( HRV) advised the Xin method of language to persuade use - | on Pro / ί inch plant Chong by k, the system being able to persuade measured as i can to persuade the autonomic nervous system measured;? mention ^ 7 plus direct and accurate means,
利用本发明,不但可以了解心率变化的超势,还可 区分某 交 ,¾神经与付交感神经之间的相互作用,改变了 已有技术中利用 j非除 推断法 ,靠检测判断是交感神经还是付交 .¾祌经兴奋性强的状态,利 用衣发明的測试糸统进行植物神经糸统劝能 if断,〈义需十五分 中 ,就 可以 到交感神经与什交感神经功能状态的定量的-: t断结果, ί'1如 ί-ϊ- ί'Ι的是 ^感神经系 ¾是忖交感 ^tti ,Ϊ" ¾兴备性 ¾、 -; M 少 ^ 数;并且治疗后是否有好转、好转程度如何,也能够很容易地从測 i式 曲线及数字上荻得结论。 The invention can not only understand the super-potential of heart rate change, but also distinguish the interaction between a certain intersection, the 3⁄4 nerve and the sympathetic nerve, and change the prior art using the non-inference method of j, and rely on the detection to judge that it is sympathetic Still paying. 3⁄4 祌 兴奋 兴奋 祌 3 3 3 3 3 3 3 3 3 3 3 3 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣 衣Quantitative -: t breaks the result, ί'1 such as ί-ϊ- ί'Ι is ^ sensory nerve system 3⁄4 is 忖 忖 ^ ^tti, Ϊ" 3⁄4 兴性性 3⁄4, -; M less ^ The number; and whether there is improvement and improvement after treatment, it is also easy to draw conclusions from the measured i-curve and numbers.
附 a概述 Appendix a Overview
通过下面结合附图对实施例的详细说明,本发明以上及其它的 目的、特征及优点能够变得更加明确。 在附图中:  The above and other objects, features and advantages of the present invention will become more <RTIgt; In the drawing:
1 为根据本发明的植物神经糸统功能測试糸统的示意 a。 图 2为根据本发明的糸统和方法的测试过程的一个实施例的示 意图。  1 is a schematic representation of a plant neurological functional test system according to the invention. 2 is a schematic illustration of one embodiment of a testing process for a system and method in accordance with the present invention.
图 3为在根据本发明的植物神经糸统功能測试系统中运行的软 ί牛流程图。  Fig. 3 is a flow chart of a soft gram running in the autonomic nervous system function test system according to the present invention.
为根据本发明的测试糸统中心电信号存贮器电原理图。 图 5为图 1所示糸统中红外接收器的示意性原理图。  It is an electrical schematic of the test system central electrical signal memory in accordance with the present invention. FIG. 5 is a schematic schematic diagram of the mid-infrared receiver of the system shown in FIG. 1.
S 6—图 12分別为不给药的对照实验中四种状态下所 ί'寻到的 S 6 - Figure 12 are respectively found in the four states of the control experiment without administration.
HKV曲线,其中: HKV curve, where:
图 6是在平卧沐位自由呼吸状志下(即图 2中 Α段中)的曲线: 图 7是在平卧体位受控呼吸状态下(即图 中 B段中)的曲线; 图 8是在站立体位自由呼吸状态下(即图 2中 C段中)的曲线; 图 9是在站立体位受控呼吸状志下(即图 2中 D段中)的曲线; 1 0是整个平卧体位时自由呼吸和受控呼吸的状态下(即图 2 中 Λ + Β = £段中)的曲线;  Figure 6 is a curve in the supine position of the recumbent (i.e., in the sacral section of Figure 2): Figure 7 is a curve in the controlled position of the supine position (i.e., in the B segment of the figure); It is a curve in the standing free breathing state (ie, in the C segment of Figure 2); Figure 9 is the curve in the standing position controlled breathing (ie, in the D segment of Figure 2); 10 is the entire supine a curve of free breathing and controlled breathing in position (ie, Λ + Β = £ in Figure 2);
m i〗 是:^个站立休位时自由呼吸和受控呼吸的状志下(即 a 中 cm i〗 Yes: ^ Under the condition of free breathing and controlled breathing in standing position (ie a c
+ D = F段中)的曲线: + D = curve in section F):
12是全部 15分钟测试过程中包括平卧体位和站立 ί本 下的 自由和受控呼吸状态下(即图 2中 A + B+C+D = E + F = R段)的曲 线。  12 is the curve for all 15 minutes of testing including the supine position and standing under free and controlled breathing (ie A + B + C + D = E + F = R in Figure 2).
13- 1, 8是与图 6 -… 12分别对应的各段时域 X信与^除直流 成份后的曲线与经过 AR模型变换后的頻城劝率诸信号 S 的吋照 ^:其中  13- 1, 8 is a comparison of the time-domain X-signal and ^-de-dc component of each segment corresponding to Fig. 6 -...12 and the signal of the frequency-sense rate signal S after the AR model transformation ^:
1 3是与 E 6所示不给 n对比实验中平卧自由呼吸的 Λ段中 X〈ί号与劝率^信号 s的对照图: 图 14是与图 7所示的 B段对应的 X信号与 S信号的对照图: 图 15是与图 8所示的 C段对应的 X信号与 S信号的对照图: 图 16是与图 9所示的 D段对应的 X信号与 S信号的对照图: 图 17是与图 10所示的 E段对应的 X信号与 S信号的吋照图: 图 18是与图 11所示的 F段对应的 X信号和 S信号的对照图: 图 19是以分段状态为 Z轴做出的 A、B、C、D四条曲线的三维曲 线图。 1 3 is a comparison chart of the X < ί and the persuasion s signal s in the squat section of the squat free breathing in the experiment compared with the E 6: Figure 14 is a comparison diagram of the X signal and the S signal corresponding to the B segment shown in Figure 7: Figure 15 is a comparison diagram of the X signal and the S signal corresponding to the C segment shown in Figure 8: Figure 16 is the same as Figure 9 A comparison diagram of the X signal and the S signal corresponding to the D segment shown in the drawing: Fig. 17 is a view showing an X signal and an S signal corresponding to the E segment shown in Fig. 10: Fig. 18 is a F segment shown in Fig. 11 Corresponding graph of the corresponding X signal and S signal: Fig. 19 is a three-dimensional graph of four curves A, B, C, and D made by the segment state as the Z axis.
图 20是以分段状态为 Z轴做出的 A、B、C、D、E、F六条曲线的三 维曲线图。  Figure 20 is a three-dimensional graph of six curves A, B, C, D, E, and F made with the segmentation state as the Z axis.
图 21是依照本发明测试糸统分析计算后给出的体位对植物神 ¾劝能影响的定量结论报告实例。  Fig. 21 is a diagram showing an example of a quantitative conclusion report on the effect of body position on plant persuasion after the calculation of the pedigree analysis in accordance with the present invention.
图 22是依照本发明测试糸统分析计算后给出的呼吸吋植物神 经功能影响的定量结论报告实例。  Fig. 22 is a diagram showing an example of a quantitative conclusion report on the effects of the function of the respiratory sputum plant after the analysis of the sputum analysis in accordance with the present invention.
本发明的最佳实施方式 BEST MODE FOR CARRYING OUT THE INVENTION
参见图 1,示出了根据本发明的植物神经糸统劝能 , 试 ,f;统的 原理 H。 在本发明的糸统中,包括一个单片机式 ECG信号采集存贮 装置 i 0,以一定的心电导联方式从受试者身上采集到不同沐位状态 和 同呼吸状态(图 2)下的 ECG信号被存贮于心电^号存贮 ; 11 之内。 @ 4示出了心电信号存贮器的电原理 H,其中: U 为中央处理 ; ^ CPU , U2为 、读存贮 iROM,U3为地址钺存器, U4 为随机存 W± AM.Uo为模数转换■!!: A/1 ,U6为线路驱动 ^,L;7为二^入《或非 门. U8 为由四个运算放大器组成的心电信号放大 ULEAD为心电 信号输入端。 通过此端采集到的心电信号经过心电放大器 ,5送 至 A /D转换器 ϋ5,送到 CPU ( U 1 )进行处理,存贮在随机存贮 S (RAM M和'口、读存贮 :(ROM)U2之中。  Referring to Figure 1, there is shown the principle of perennial, experimental, and f-systems according to the present invention. In the system of the present invention, a single-chip ECG signal acquisition and storage device i 0 is included, and the ECG under different posture states and the same breathing state (Fig. 2) is collected from the subject by a certain ECG lead. The signal is stored in the ECG storage; 11 within. @4 shows the electrical principle H of the ECG signal memory, where: U is the central processing; ^ CPU, U2 is, read and store iROM, U3 is the address buffer, U4 is the random memory W± AM.Uo For analog-to-digital conversion ■!!: A/1, U6 is the line driver ^, L; 7 is the binary input into the NOR gate. U8 is the ECG signal amplified by four operational amplifiers. ULEAD is the ECG signal input terminal. . The ECG signal collected through this end passes through the ECG amplifier, and is sent to the A/D converter ϋ5, sent to the CPU (U1) for processing, and stored in the random storage S (RAM M and 'port, read and save Storage: (ROM) U2.
在本实施例中,采集和存贮 15分钟心电信号。 参 LS 2,因为平 卧的 ί本位和比自由式呼吸速度快的受控呼吸分別刺激计: 惑神经 .而站立的体位和自由式呼吸则分别刺激交感神经糸 ¾。所以本发 明 -Hf 15分钟分成这样四个分別对交感和 /或付交 ,¾神经系统进行不 同剁激的阶段:在第一段时间 A 中,受 i久者采取平卧沐 {ί (刺激付 感神经)自由地呼吸(刺激交感神经);第二段时间 B,受试者体位仍 为平卧(刺激付交惑神经),但改成受控呼吸,即在由语音单元给出 一 快于自由呼吸的节拍的引导下进行吸呼(刺激付交感神经 ):在 第三段时间 C中,受试者体位由平卧改为站立(刺激交感神经),自 由式呼吸(刺激交惑神经);第四段时间 D为受试者为站立(刺激交 感神经)的受控式呼吸(刺激付交感神经)。 在本实施例中,Α段为 3 分忡: β段为 4分钟: C段为 4分钟且其中第一分钟内的信号为人体 由平卧体位变为站立休位过程中的信号,在处理中特殊对待; D段也 为 4分钟。心电信号存贮 _ 在 15分钟内连续地測试这四种不同体位 呼吸方式下的心电信号。通过一个红外发射^ 12 (参见图 1 ), 所存 ^的心电信号传输給微型计算机 23。 微机 23是通过接口 22与红外 接收器 21相连接,进而接收由红外接收器 21 所接受到的心电信号 ( tX、G)。 In this embodiment, a 15-minute ECG signal is acquired and stored. Refer to LS 2, because the supine ί position and the controlled breathing faster than the free-style breathing rate are separately stimulating: Concealed nerves. Standing and free breathing stimulate the sympathetic nerves, respectively. Therefore, the present invention-Hf 15 minutes is divided into four stages of different sympathetic and/or paying, and the 3⁄4 nervous system is stimulated differently: in the first period of time A, the person who is a long time takes a flat sleep {ί (stimulation) Pay Sensory nerve) free breathing (stimulation of sympathetic nerves); in the second period of time B, the subject's position is still supine (stimulation pays the nerve), but changed to controlled breathing, that is, given a fast by the speech unit Exercising under the guidance of free-breathing beats (stimulation and sympathetic nerves): In the third period of time C, the subject's position changed from supine to standing (stimulating sympathetic nerves), free-style breathing (stimulating sympathetic nerves) The fourth period of time D is the controlled breathing of the subject (stimulation of sympathetic nerves) (stimulation of sympathetic nerves). In this embodiment, the segment is 3 minutes: the β segment is 4 minutes: the C segment is 4 minutes and the signal in the first minute is the signal during the change from the supine position to the standing position. Special treatment; D segment is also 4 minutes. ECG Signal Storage _ The ECG signals in these four different body position breathing modes were continuously tested in 15 minutes. The stored electrocardiographic signal is transmitted to the microcomputer 23 via an infrared emission ^ 12 (see Fig. 1). The microcomputer 23 is connected to the infrared receiver 21 via the interface 22, and further receives the electrocardiographic signals (tX, G) received by the infrared receiver 21.
图 5示出了可用于本发明糸统的红外接收 ^ 21的原理 S。其中 经红外接收管 D1所接收的信号通过运算放大器 IC1迸行运算放大, 在比较 ·!!: IC2进行比较运算之后被 ^相 If IC3反相,再经由线 云力 ^ 1C 驱动而输出,该输出信号 D。u,经插座 S2送至微机 23的 RS232 "。 图中 S]、S2、S3为插座。 当然,也可以不采用红外线传输而采用 有线传输的方式实现心电信号存贮 · 与微计算机之间的信号传送, 这时可以利用驱动芯片与微机的串(亍通信接口相连。 Figure 5 shows the principle S of an infrared receiver 21 that can be used in the system of the present invention. The signal received by the infrared receiving tube D1 is operated and amplified by the operational amplifier IC1, and is compared by the comparison of !!!: IC2 is inverted by the phase If IC3, and then output by the line cloud force ^ 1C, which is output. Output signal D. u , RS232 sent to the microcomputer 23 via the socket S2. In the figure, S], S2, and S3 are sockets. Of course, it is also possible to realize the storage of the electrocardiogram signal by means of wired transmission without using infrared transmission. The signal transmission, at this time can be used to connect the driver chip to the string of the microcomputer (亍 communication interface.
在本发明的测试糸统中,还提供有一个由微机 23控制的语音单 元和扬声器,用以发出指挥受试者动作(从卧位到站立、从自 由呼吸 到 ±控呼吸等)的命 、。 当然,这 、语言单元和杨声器也可以与便指 式心电信号米集和存贮装置 10做在一起。  In the test system of the present invention, there is also provided a voice unit and a speaker controlled by the microcomputer 23 for issuing the life of the subject (from lying position to standing, from free breathing to ± controlling breathing, etc.) . Of course, the language unit and the speaker can also be combined with the finger-type ECG signal set and storage device 10.
微机 23中可以包括语音卡、多功能卡、显示卡硬盘、软驱、主板、 电源等。 还带有一个输出装置 24,用以打出不同段中的时城 X信号 和 城的 S信号的曲线和分析报告(参 ! 图(—图 22) υ The microcomputer 23 may include a voice card, a multifunction card, a display card hard disk, a floppy disk drive, a main board, a power source, and the like. 24 also has an output device for analysis and hooking the S signal when in the different sections of the city and urban signal X (see FIG. (! - FIG. 22) υ
图 3示出了微机处理 ECG i 号,进行劝率语分析,从而作出 . 神经、付交感神经糸统劝能状态的定量结果的软件^程图.,  Figure 3 shows the software processing of the ECG i number, the persuasion analysis, and the quantitative results of the neural and sympathetic neural system.
参 !/ L图 3 ,由心电信号采集和存 装置 1 0送出的心电^号½红 一 X - 外传输之后送入微计算机 32。在微计算机 32中,首先进行一定时间 例如 5秒钟的心电图自学习,进入 R波识别步骤 S12,采用自适应判 据,用一阶导数来识别 R波,送出 R波序列信号(即按先后顺序采集 的 R— R间期值)。 它包括用低通差分来求得 ECG的一阶导数 参! / L Figure 3, by the ECG signal acquisition and storage device 10 sent out the ECG ^ 1 1 red red X - The external transfer is sent to the microcomputer 32. In the microcomputer 32, the electrocardiogram self-learning is performed for a certain period of time, for example, 5 seconds, and the R wave identification step S12 is entered. The adaptive criterion is used to identify the R wave by the first derivative and the R wave sequence signal is sent (ie, sequentially R-R interval values collected sequentially. It includes using low-pass differential to find the first derivative of the ECG
d(i) = ECG(i)-ECG(t-4)  d(i) = ECG(i)-ECG(t-4)
吋 ECG信号的一阶导数进行低通滤波,得到:  一 The first derivative of the ECG signal is low-pass filtered to obtain:
l)+d(i)—d (卜 6)  l) +d(i)-d (Bu 6)
然后对 f(t)找出最大绝对值 PK及两个 R— R间隔。 Η。(Ό)=0.7 X ΡΚ作为识別 R波的阔值,两个 R— R间期的平均值作为平均 R— R 间隔 R AV的初始值。 经过顺序计算 f (t )找出 ΡΚ ( η ) >Η0 ( η )的点 , 以便确定是否 R波及 R波的位置。这里,阈值自适应的递归公式为: Then find the maximum absolute value PK and the two R-R intervals for f(t). Hey. (Ό) = 0.7 X ΡΚ As the threshold for identifying the R wave, the average of the two R-R intervals is taken as the initial value of the average R-R interval R AV . The points of ΡΚ( η ) > Η 0 ( η ) are found by sequentially calculating f (t ) to determine whether the positions of the R wave and the R wave are. Here, the recursive formula for threshold adaptation is:
0. 7 * ΡΚ (π)<1.5 * Ηο(η) 0. 7 * ΡΚ (π)<1.5 * Ηο(η)
0.7 * ΡΚ (")>】.5 *- Η0(") 1.5* RKAV(„) W-ft>0 5 HJiAV(n) 其它 然 )3,在步骤 S 13对所得到的 R— R间期时域信号进分 Jt和预处理。 即按照图 2所示的分段(A、B、C、D和代表整个平卧体位的 E役及代 表整个站立体位的 F段)对所得到的 R— R间期时城信号(R波序列 信号)进行截取和处理,在这里 ^每一段被分出的 R波 Η信号称 作 X信号,它即为分段的 R— R间期时域信号。 图 16-18是在对受 i 者不施加药物时所做的对照实验记录的 R— R间期波形。 其中图 18是整个 R— R间期波形图,而图 16—] 7则分別为 A、B、C、D、h;、 F 段的 R— R间期波形。 在图中标明的符号" ΧΑ1200Α"·"ΧΒ1200Λ" • ·… ·中,第二个字母表示该曲线所取自的分段标号,最 )β一 字母表 示实验的性质.即有否给药。这里 Α代表未给药的实验 . 如: Η 17中 f示明 "XB1200Α"表示该曲线为 Β段即平卧 ±控 呼 h'n 、表给 ¾ ύι) Η照实验:义如图 10中标明的 "ΧΕ1200Λ "则代表 曲 为 li rt -'p f 1、平卧自由呼吸加受控呼吸段的未給 的吋照实验,等等,其 类 0.7 * ΡΚ (")>].5 *- Η 0 (") 1.5* RKAV(„) W - ft>0 5 HJiAV(n) Otherwise, 3, the obtained R-R interval time domain signal is divided into Jt and preprocessed in step S13. That is, according to the segment shown in Fig. 2 (A, B, C, D and the E-station representing the entire supine position and the F-segment representing the entire standing position), the obtained R-R interval time signal (R wave) The sequence signal is intercepted and processed. Here, the R-wave signal that is divided in each segment is called the X signal, which is the segmented R-R interval time domain signal. Figures 16-18 are R-R interval waveforms recorded in a control experiment performed when no drug was administered to the subject. Figure 18 is the entire R-R interval waveform, while Figure 16-7] is the R-R interval waveform of A, B, C, D, h; In the figure, the symbols "ΧΑ1200Α"·"ΧΒ1200Λ" • ·... ·, the second letter indicates the segmentation number from which the curve is taken, and the most) β letter indicates the nature of the experiment. Here, Α represents an unadministered experiment. For example: Η 17 f indicates "XB1200Α" indicates that the curve is a squat section, ie, a flat squat, a control h'n, and a table gives 3⁄4 ύ ι ). The "ΧΕ1200Λ" marked in the middle represents the song as li rt -'pf 1. Uncontrolled squatting experiment of supine free breathing plus controlled breathing, etc.
¾应当指出的是,为了测试的准确性, P万止 ¾检,在系统的处 .f ¾中还提供有回检劝能,当 R— R> 1.8RRAV时,吋中 in]可能的 ¾ 检进行回检,回检的阈值为: 3⁄4 It should be pointed out that for the accuracy of the test, P is only 3⁄4, and there is also a feedback check in the system. f 3⁄4, when R-R> 1.8RRAV, in中in] possible 3⁄4 Check the checkback, the threshold for the checkback is:
H,(n) ::0.5 * Ho(n)  H,(n) ::0.5 * Ho(n)
在对 R- - R间期进∑ M行上述分析处理之后,从步骤 S21 开始,利用  After the above analysis processing is performed on the R--R interval, the processing proceeds from step S21.
1  1
回归(AR)模型进行镨估计。  The regression (AR) model is used for 镨 estimation.
下面 Λ I明本发明所采用的自回归( Α )模 估计的基本原理 根据 Woid分解定理,一平段的随机信号 X (n )可以看成由谱密 度 - o的白噪声 W(n)激励某一沖 Σ M激响应为 h( n )的线性糸统所产 生,即:  The following is the basic principle of autoregressive ( Α ) modulus estimation used in the present invention. According to the Woid decomposition theorem, a flat random signal X (n ) can be regarded as a white noise W(n) by spectral density - o. A linear system with a shock response of h( n ), ie:
Xn— Wn ¾ hn ( * 卷积) Xn— Wn 3⁄4 hn ( * convolution)
贝 '1 Sx(^)= Sw ( ) |fi ( ) I2 贝'1 Sx(^)= Sw ( ) |fi ( ) I 2
其中 Sw,S 分別为输入和输出的劝率诸, H是糸统的频半特性或传 函数。 Θ此, 、要 H(Z)已知,随机信号的劝率善 SxW'、)便可求 H (Z)即是随机佶号的参数模型。 Where Sw, S are the persuasion rates of the input and output, respectively, and H is the frequency-semi-characteristic or transfer function of the system. In this case, H(Z) is known, and the random signal is good for SxW', and H (Z) is a parametric model of random apostrophes.
自回归(AR)模型乂称全极点模型,其表达式如下:  The autoregressive (AR) model nicknames the all-pole model, and its expression is as follows:
Xn = - n Xn = - n
K  K
Z变 : _ _lz)_ 1 Z change : _ _lz)_ 1
H(Z  H (Z
W (Ζ) W (Ζ)
0  0
替换页 (细则第 26糸) 4得 ΛΚ梭¾!参 及白 号的 Replacement page (Article 26) 4 get the shuttle 3⁄4! Participate in white Number
∑ M ^  ∑ M ^
其中 f 为 o频率(Hz), At为采样间隔。  Where f is the o frequency (Hz) and At is the sampling interval.
AR模型参敖的估计包括:模型糸数。., ά 声 ^密度 No . 和'钹¾!的阶次 M  The estimation of the AR model parameters includes: model parameters. ., ά ^ ^ Density No . and '钹3⁄4! Order M
∑ i  ∑ i
计的万法不 <一 1种,这里?、举例说明程序中 ^用的《向 us The method of counting is not one or one, here? For example, the program used in the program
( 小平方)预測的 MARPLE法。 此种万法比轻典型的 tkisg算法,具 有更高的频率分辨率,没有谱成分分裂观察,而且领半漂移较小,在 :卜 量丄具有相等程度,同 AR的平才成正比。 基本 - 如下: (Small square) predicted MARPLE method. This kind of twisg algorithm with a typical method is higher than the typical tkisg algorithm, and there is no spectral component splitting observation, and the half-drift is small, and the degree is equal to the level of the AR. Basic - as follows:
设有一全极点平段随机过程,从( 1 )式中 '了 1伸出前「 及后 Γ¾预 »\ 分別如下式所示:  There is a full-pole flat-section random process, from (1) where '1 is extended before' and then Γ3⁄4 pre-» are as follows:
前向预测误差: f Μ,Κ 二 K M,i 人 K+M-i l^K^N - h (3)  Forward prediction error: f Μ, Κ 2 K M, i person K+M-i l^K^N - h (3)
Μ, - ^ - M aM.o - 1 : : AR镆型阶次; N: X数据长度 Μ, - ^ - M a M .o - 1 : : AR镆 order; N: X data length
根据最小均万准则,使前、后向预測误差之和 e、, 为最小来求 ^ According to the minimum mean criterion, the sum of the front and back prediction errors e, , is the minimum
\R模 参数, OMI , ,…,Ο .Μ, \R mode parameters, OMI, ,...,Ο .Μ,
Ν-Μ Ν-Μ  Ν-Μ Ν-Μ
∑ ∑  ∑ ∑
Μ,Κ (5)  Μ, Κ (5)
Κ=1 Κ=1
; 2 : ; 2 :
¾ (i,j ) = ' . ( ) i d:: 3⁄4 (i,j ) = ' . ( ) i d::
替换页 (细则第 26糸) IU式(6),(8)可以组成一令(iM+1) X (M+ 1 )的矩阵 Replacement page (Article 26) IU equations (6), (8) can form a matrix of one order (iM+1) X (M+ 1 )
RM八 M ~ (9)  RM eight M ~ (9)
其中 o, among them o,
然, 要求得 RM,用线性代数的方法,可由(9)式求出 AR模 参 However, R M is required , and the method of linear algebra can be used to find the AR mode parameter from (9).
A 二 R EM ( 1】 ) A two R EM ( 1 )
但若采用直推计算法,所需计算量大,这里利用 RM矩阵的埃尔米特 及反埃尔米特特性进行推导。 However, if the direct push calculation method is used, the calculation amount is large, and the Hermit and the anti-Ermite characteristics of the R M matrix are used here to derive.
首先,增设两个误差值 em ', em  First, add two error values em ', em
, N-M-1  , N-M-1
2 2
ifM,K+r 3 (12) f , N-M-1If M ,K+r 3 (12) f , NM-1
据最小均 Κΐ准则, 前述的 eM同样处理 即: According minimum mean Κ ΐ criterion, the same treatment i.e., the e M:
( 14)  (14)
(15)  (15)
替换页 (细则第 26条) N- 1-1 Replacement page (Article 26) N- 1-1
= Λ ( L-j W +½+j ½+i〕 (17) = Λ ( Lj W + 1⁄2 + j 1⁄2+i) ( 17)
Λ=Λ =
M 二 (18)M II (18)
最后推导出八 M,的时域更新公式: Finally, the time domain update formula of eight M, is derived:
(19)  (19)
以及 AR模型糸数迭代公式: And the AR model parameter iteration formula:
l i m (20) 在式(19)中:  l i m (20) In equation (19):
(21)  (twenty one)
M M
+1二 ( D¾) +^ ½+1 (22) 式(20)具有同 Levinson迭代同样的形式,由此可求得 AR馍型参数, 及白噪声谱密度 No。 +1 2 (D3⁄4) + ^ 1⁄2 + 1 (22) Equation (20) has the same form as the Levinson iteration, from which the AR馍 parameter and the white noise spectral density No can be obtained.
吋 M阶 A 模型最后得到其参数: No=em, The 吋M-order A model finally obtains its parameters: No=e m ,
则劝率密度为 Persuade rate density
M  M
∑ aK exp (-j 2KfKAt ) 2 在模型参数估计中,另外一个关键的问题就是模型阶次 M的^ 择,这是一个重要但又尚未解决好的问题。 阶次过低,作出的镨估计 会使实?示存在的语峰变得模糊;阶次过高,又会产生虛假的细节。 在 本发明程序中,本发明人经过反复 ^验,计算、比较、结 ,发现逸 在 11一 19阶之间能够满足信息论准则的阶次,得到 7 A 的结果 . 这里所指信息论的准则是: d (M+l) ∑ a K exp (-j 2KfKAt ) 2 Another key issue in model parameter estimation is the choice of model order M, which is an important but unresolved problem. If the order is too low, what is the estimated estimate? The peaks of existence are blurred; the order is too high, and false details are produced. In the procedure of the present invention, the inventors have repeatedly tested, calculated, compared, and concluded that the order of the information theory criterion can be satisfied between the 11th and 19th steps, and the result of 7 A is obtained. The criterion of the information theory referred to herein is : d (M+l)
A I = Ln©M  A I = Ln©M
N  N
1 "5 替换页 (细则第 26糸) 根据前述,预測的均方误差 em总是随阶次 M的增加而下降,而 α(Μ + 1)/Ν则随 Μ增加而上升,这样就有可能在某一 Μ 值下取得 极小。 这个极小点的 Μ值便被逸为.最诖阶次。 1 "5 replacement page (rule 26) According to the foregoing, the predicted mean square error e m always decreases with the increase of the order M, and α(Μ + 1)/Ν increases with the increase of the ,, so that it is possible to obtain a minimum under a certain value. . The devaluation of this tiny point is deducted as the most orderly order.
在求得 AR模型参数及白。桑声 ^密度 No后,就很容易在步骤 S22利用下式来估计信号的劝率谱密度(PSD) :  In the AR model parameters and white. After the density of No., it is easy to estimate the signal spectral density (PSD) of the signal using the following formula in step S22:
Sx (f) = Ν。 / |l+ ¾ K exp (-j27ifkAt) I2 S x (f) = Ν. / |l + 3⁄4 K exp (-j27ifk A t) I 2
K一 1 ' '  K-1' '
其中 f 为頻率(Hz),At为采样间隔。 Where f is the frequency (Hz) and At is the sampling interval.
13至 18示出了一个未给药的对照实验的各 X信号波形和 经过以上 AR模型变换之后得到的各段对应的劝率诸 S信号曲线的 吋比。 其中图 13为对应于受试者取卧位自由呼吸的阶段 A的功半 ^密度,图 14 为对应于受试者取卧位受控呼吸的阶段 B的劝率诸密 度,图 15为对应于受试者取立位自由呼吸的阶段 C的劝率语密度, ¾ 16 为对应于受试者取立位受控呼吸的阶段 D的劝率语 ^度,图 17 为吋应于受试者馭卧位自由呼吸和受控呼吸的阶段 E的 J力率^ 度.而图 18则是对应于受 i式者取立位自由呼吸和受控呼 的阶段 13 to 18 show the ratios of the X signal waveforms of an unadministered control experiment and the corresponding S signal curves of the respective segments obtained after the above AR model transformation. 13 is the work half density corresponding to the stage A of the subject's free breathing, and FIG. 14 is the density of the persuasion rate corresponding to the stage B of the subject's controlled position breathing, FIG. 15 corresponds to The persuasion rate of the stage C in which the subject takes a free breathing, 3⁄4 16 is the persuasion rate corresponding to the stage D of the subject taking controlled breathing, and Figure 17 is the subject. The J-force rate of the stage E of free-breathing and controlled breathing in the lying position, and Figure 18 is the stage corresponding to the free breathing and controlled call of the standing type.
I'的劝半^密度。 I's persuaded half density.
在步骤 S23,根据上述^率镨密度结果,计算出各特征值.给出 如图 21 和由 22所示的结论报告,以供医生作为诊断的依据。在表中 以及各条曲线中所用的符号意义如下:  In step S23, each feature value is calculated based on the above-described rate 镨 density result. A conclusion report as shown in Fig. 21 and 22 is given for the doctor to use as a basis for diagnosis. The meanings of the symbols used in the tables and in the various curves are as follows:
T—— R— R间期平均值(ms)  T——R—R interval average (ms)
VAR1 (有时标为 V)—— R— R间期均方差(ms2) VAR1 (sometimes labeled V) - R-R interval mean square error (ms 2 )
P一一总劝率(归一化后等于均方差)(ms2) P-one general persuasion rate (normalized to equal mean square error) (ms 2 )
PL——低頻功率(0· 02—0. 15Hz)(ms2) PL - low frequency power (0 · 02 - 0. 15Hz) (ms 2 )
PH——高频功率(0.15—0.40Hz)(ms2) PH——High frequency power (0.15—0.40Hz) (ms 2 )
LP——低頻中心频率(Hz)  LP - low frequency center frequency (Hz)
HF- 高频中心頻率(Hz)  HF- high frequency center frequency (Hz)
rPLH - -PL/PH低频劝率 /高頻功率  rPLH - -PL/PH low frequency advisory rate / high frequency power
rS LH S L /SH PSD低频峰值 /PSD ,¾頻峰值  rS LH S L /SH PSD low frequency peak /PSD, 3⁄4 frequency peak
替换页 (细则第 26条) PSD—劝率密度诸 Replacement page (Article 26) PSD - Persuasion rate density
参见图 1 9和 20,本发明还作出了以分段作为 Z轴的各段劝率 ? if密度比较图。 可以清楚直观地看出在各种刺激状态下交感神经和 付交感神经的兴奋性情况。在两图中,曲线的第一組尖峰示出了交感 和付交感神经总的活动强度,第二組尖峰则是付交感神经单独兴奋 时的强度。 这为医生提供了对病人植物神经糸统劝能状态直观的和 其中交感和付交感神经相互作用的直接的 据和报告。 ' 以上各处理装置及过程可以由计算机软件程序来完成,在本发 明中,提供了一种特别适用于在本发明的植物神经糸统劝能测试糸 统中运行的应用软件。  Referring to Figures 19 and 20, the present invention also makes the segmentation rate as a Z-axis by segmentation? If density comparison chart. The excitability of the sympathetic and sympathetic nerves under various stimuli can be clearly and intuitively observed. In both figures, the first set of peaks of the curve shows the total activity of the sympathetic and sympathetic nerves, and the second set of peaks is the intensity of the sympathetic nerves when excited alone. This provides the doctor with a direct report and report on the patient's autonomic sensational state and the sympathetic and sympathetic interactions. The above various processing devices and processes can be performed by a computer software program, and in the present invention, an application software that is particularly suitable for use in the plant neuron stimulation test system of the present invention is provided.
为了 1解人体植物神经糸统的劝能,本发明对如下四种实验结 果进行比较:  In order to solve the persuasiveness of the human plant neuron system, the present invention compares the following four experimental results:
实验〗:对照实验。 它是不对人体施加外界药物,即不扰动植物 神 ^ 统的情况:  Experiment〗: Control experiment. It is a situation in which no external medicine is applied to the human body, that is, it does not disturb the plant.
实验 2:注射阿托品(atropine ) ,以刺激交感祌经系统的兴奋性: 实验 3:服用心得宁( propranolol ),以刺激付交感神经糸统的兴 Experiment 2: Injecting atropine to stimulate the excitability of the sympathetic system: Experiment 3: Taking propranolol to stimulate the sympathetic nervous system
^性: ^Sex:
实验 4:同时给药阿托品和心得宁,对交感和付交感祌经糸统进 f扰动。 Experiment 4: Simultaneous administration of atropine and propranoline, and sympathetic and sympathetic sensation through the sputum.
表 1 是对 20例进行实验而茯得的关于体位运动和药物对 R— R间 期变异性的影响的统计结果。 这里及 / 续表中所用的字母符号的意 义与前面提及的蚬定相同。 Table 1 shows the statistical results of the effects of postural motion and drug on R-R interval variability in 20 trials. The meanings of the alphabetic symbols used here and / in the continuation table are the same as those mentioned above.
表 1 状 态 T(ms) V t2) LF(Hz ) Table 1 State T(ms) V t 2 ) LF(Hz )
1. 未给葯:  1. Not administered:
Ε. 平卧 (m) 891 3992 30. 0 0. 099 Ε. Flat (m) 891 3992 30. 0 0. 099
(sd) 123 2431 10. 6 0. 019  (sd) 123 2431 10. 6 0. 019
F. 站立 (m ) 727 3400 " " 46. 4 1 0. 083 F. Standing (m) 727 3400 "" 46. 4 1 0. 083
(srf) 96 1506 11. 9 0. 015  (srf) 96 1506 11. 9 0. 015
2. Atropine:  2. Atropine:
Ε. 平卧 (《) 937 ' 5662 ' 28. 3 0. 094 Ε. Flat (") 937 ' 5662 ' 28. 3 0. 094
Csd) 145 3496 14. 0 0. 020  Csd) 145 3496 14. 0 0. 020
F. 站立 Cm ) 644 · ' · '2926 ' 37. 7 0. 084  F. Standing Cm ) 644 · ' · '2926 ' 37. 7 0. 084
(sd) 114 1841 16. 7 0. 021  (sd) 114 1841 16. 7 0. 021
3. Propranolol:  3. Propranolol:
E. 平卧 (m) 955 * 5417 35. r 0. 103  E. Flat (m) 955 * 5417 35. r 0. 103
(sd) 133 3582 10. 7 0. 017  (sd) 133 3582 10. 7 0. 017
F. 站立 (《) 828 ' ' · •3794 ' 43. 5 ' 0. 084  F. Standing (") 828 ' ' · • 3794 ' 43. 5 ' 0. 084
(s«/) 105 2445 9. 7 0. 016  (s«/) 105 2445 9. 7 0. 016
4. 以上 2和 3中  4. Above 2 and 3
R 2296 的葯同时給 -R 2296 of the medicine is given at the same time -
E. "f卧 (m) 1026· · 5817· 32.2 0.094 E. "f bedroom (m) 1026 · · 5817 · 32.2 0.094
124 2791 13.1 0.022 124 2791 13.1 0.022
F. 站立 On) 795' •3515 37.2· 0.090 F. Standing On) 795' • 3515 37.2· 0.090
126 2326 11.4 0.022 表 1(续) 状 态 HF(Hz) PL/PH SL/SH 126 2326 11.4 0.022 Table 1 (continued) Status HF(Hz) PL/PH SL/SH
1. 未給葯, Not administered,
E. 平卧 (ffi) 27.0 0.280 1.388 1.535  E. Flat (ffi) 27.0 0.280 1.388 1.535
11.9 0.062 0.987 1.463 11.9 0.062 0.987 1.463
P. 站立 On) 11.1 0.259 • ' 4.999 ' '9.862 P. Standing On) 11.1 0.259 • ' 4.999 ' '9.862
5.3 0.065 2.220 6.407 5.3 0.065 2.220 6.407
2. Atropine: 2. Atropine:
E. 平卧 On) 20.6" 0.275 1.986· 3.664·  E. Flat lay On) 20.6" 0.275 1.986· 3.664·
(« ) 13.4 0.065 1.587 5.272 (« ) 13.4 0.065 1.587 5.272
F. ¾立 On) 7.3· ' 0.248 • * 5.702 ' 12.336F. 3⁄4立 On) 7.3· ' 0.248 • * 5.702 ' 12.336
(sd) 3.1 0.066 2.825 10.036(sd) 3.1 0.066 2.825 10.036
3. Propranolol: 3. Propranolol:
E. 平卧 On) 22.7 0.274 1.970 1.738 E. Flat lay On) 22.7 0.274 1.970 1.738
(srf) 9.9 0.066 1.352 1.668(srf) 9.9 0.066 1.352 1.668
F. 站立 (#n) 11.7 0.253 • ' 4.190 ' 8.149 F. Standing (#n) 11.7 0.253 • ' 4.190 ' 8.149
(id) 4.6 0.070 1.593 9.262 (id) 4.6 0.070 1.593 9.262
4. 以上 2和 3中 4. Above 2 and 3
7 -- 的药同时給: 7 -- The medicine is given at the same time:
E. 平卧 On) 21.6 0.277 1.897  E. Flat lay On) 21.6 0.277 1.897
( ) 11.2 0.074 1.249  ( ) 11.2 0.074 1.249
F. 站立 (m) ' " 10.3 0.241 * " ' 4.365 • ' "7.512·  F. Standing (m) ' " 10.3 0.241 * " ' 4.365 • ' "7.512·
(sd) 5.1 0.063 2.175 5.395 其中,数据前标明的星号表示各状态下 E (平卧体位的自由呼吸加受 控呼吸段)与 F (站立休位的自由呼吸加受控呼吸段)的比较(即体位 变化的情况统计);数据后的星号分别表示在第 2(给药阿托品 )、第 3(给药心得宁)及第 4(同时给阿托品和心得宁)的状态与对照状态 1 (不给药状态)的比较(即药物影响的情况统计)。 其中一个星号 " 示统计值 P<0.05;两个星号" * * "表示 P<0.01 ,三个星号 ·' * X ' "表示 P<0.001,它们表明有显著性差异的强度。  (sd) 5.1 0.063 2.175 5.395 where the asterisk indicated before the data indicates the comparison of E (free breathing plus controlled breathing zone in supine position) and F (free breathing plus controlled breathing segment in standing position) in each state (ie, the statistics of body position changes); the asterisks after the data indicate the status and control status of the second (administration of atropine), the third (administration of heart) and the fourth (both atropine and heart) Comparison of (no drug administration status) (ie, statistics of drug effects). One of the asterisks "shows a statistical value of P < 0.05; two asterisks "* * " indicate P < 0.01, and three asterisks · ' * X ' " indicate P < 0.001, which indicate a significant difference in intensity.
首先看休位对心率谱的影响:  First look at the impact of rest on the heart rate spectrum:
从表.1的统计结果可以看出,利用本方法,当人体从卧位到立位 时.其心率诸上的变化可以明显地检测出来。 在对照实验 1 中(不用 ),在卧位时,有两个主要的频率分量:低頻(〜0.099H/)30.0士 in.6 % ,高頻(〜0.280Hz)27.0±11.9%;PL/PH为丄.4±1。 在立位 时,低频(〜0.083Hz) 46.4±11·9%,高频(0.259Ηζ)11. ] ±5.3%: PL/PH为 5.0±2.2。可见,正常人从卧位到立位时,代表交感和付交 , 神经共同作用的低频分量增加,代表付交感神经单独作用的高频 分量减小。 明从卧位到立位时,交感神经活性增加,付交感神经活 性相对减弱。 从 R— K间隔上看,付交感神经也是减少的,即心率增 快 ;, 从统计上看,几种变化的 P值均小于 0.001,说明有很明显的差 另外,在其余三组用药的情况下,从卧位到立位, R—R 均值 ( T )、 PL、 PH、 PL/PH、 SL/SH 都有显著性差异, 、是其变化与对照 实验有所不同,这给出这样一个提示,即正常人中体位对心率普的影 是比轻大的,在一般较小的药物扰动下,仍能够表现出来。 而在 '」、 月 梗塞及糖尿病已影响到神经系统的病人中,从卧位到立位,其低频 分量则元明显增加。It can be seen from the statistical results in Table 1. With this method, when the human body is from the lying position to the standing position, the changes in the heart rate can be clearly detected. In Control Experiment 1 (not used), there are two main frequency components in the supine position: low frequency (~0.099H/) 30.0 ± in. 6 %, high frequency (~0.280 Hz) 27.0 ± 11.9% ; PL/ PH is 丄.4±1. In the standing position, low frequency (~0.083Hz) 46.4±11.9%, high frequency (0.259Ηζ) 11.] ±5.3%: PL/PH is 5.0±2.2. It can be seen that when the normal person from the lying position to the standing position, it represents the sympathetic and paying, and the low-frequency component of the nerve interaction increases, which means that the high-frequency component of the sympathetic nerve alone is reduced. From the lying position to the standing position, the sympathetic nerve activity increases, and the sympathetic nerve activity is relatively weakened. From the R-K interval, the sympathetic nerve is also reduced, that is, the heart rate is increased ; statistically, the P values of several changes are less than 0.001, indicating that there is a significant difference. In addition, in the other three groups of medication In the case, from the lying position to the standing position, the R-R mean (T), PL, PH, PL/PH, SL/SH have significant differences, and the change is different from the control experiment, which gives One suggestion is that the position of the normal person in the heart rate is more than that of the heart rate, and it can still be expressed under the general small drug disturbance. And in ', In the case of menstrual infarction and diabetes, which affect the nervous system, the low frequency component increases significantly from the lying position to the standing position.
给出了对 20例进行实验而荻得的关于呼吸及药物对 R— R 间期变异性的影响的统计结果。 The statistical results of the effects of respiration and drugs on R-R interval variability were obtained for 20 experiments.
表 2  Table 2
A/C-. 自由呼吸頻率 受控呼吸頻率(0.33ffz) A/C-. Free breathing rate Controlled breathing rate (0.33ffz)
状 态 r(wis) Vims1) PL .%) LF( z) State r(wis) Vims 1 ) PL .%) LF( z)
1. 不給药:  1. Not administered:
A. 平卧 (iw) 901 3424 41- 8 0.100 A. Flat (iw) 901 3424 41- 8 0.100
sd) 119 1982 12.4 0.021  Sd) 119 1982 12.4 0.021
887 2956 •■ 31.3 0.095  887 2956 •■ 31.3 0.095
(sd) 128 2064 12.8 0.019  (sd) 128 2064 12.8 0.019
C. 站立 (m) 728 3699 55.0 0.088  C. Standing (m) 728 3699 55.0 0.088
(srf) 95 2108 12.9 0.026  (srf) 95 2108 12.9 0.026
D. 站立 <m) 721 " · 2642 50.8 0.086 D. Standing <m) 721 " · 2642 50.8 0.086
(sd) 102 1371 13.3 0.016  (sd) 102 1371 13.3 0.016
2. Atropine:  2. Atropine:
Λ. 平卧 (w) 956ΔΔ 5076 42.0 0.096 Λ. Lying (w) 956 ΔΔ 5076 42.0 0.096
(sd) 154 3256 12.3 0.026  (sd) 154 3256 12.3 0.026
B. 平卧 (m) 922 • · 3469 • · 31.7 0.091  B. Lying (m) 922 • · 3469 • · 31.7 0.091
(sd} 147 2596 9.7 0.021 C. 站立 (m) 667ΔΔ 3144 51.0 0.079 (sd) 112 2117 14.3 0.017 (sd} 147 2596 9.7 0.021 C. Standing (m) 667 ΔΔ 3144 51.0 0.079 (sd) 112 2117 14.3 0.017
D. 站立 On) 1690Δ 47.8 0.083 D. Standing On) 1690 Δ 47.8 0.083
(sd) 115 1265 17.1 0.023 (sd) 115 1265 17.1 0.023
3. 3.
A. 平卧 (ΛΙ) 961Δ 5145Δ 43.3 0.098 isd) 135 3823 9.2 0.017A. Lying (ΛΙ) 961 Δ 5145 Δ 43.3 0.098 isd) 135 3823 9.2 0.017
B. 平卧 (m) 956Δ 4061 39.2' 0.102 B. Lying (m) 956 Δ 4061 39.2' 0.102
136 3097 12.4 0.021  136 3097 12.4 0.021
C. 站立 (m) 830ΛΛΔ 3943 54.0 0.090 C. Standing (m) 830 ΛΛΔ 3943 54.0 0.090
(sd) 110 2610 11.6 0.024  (sd) 110 2610 11.6 0.024
D. 站立 (m) 828ΔΔΔ 2957 45.4 0.081 109 1957 11.3 0.017D. Standing (m) 828ΔΔΔ 2957 45.4 0.081 109 1957 11.3 0.017
4. 同时給 2和 3中 4. Give both 2 and 3
的两种药:  Two drugs:
ΔΔΔ  ΔΔΔ
A. 平卧 (》!) 1036 6031' 42.1 0.094  A. Flat lay ("!!) 1036 6031' 42.1 0.094
(sd) 115 3590 10.7 0.022(sd) 115 3590 10.7 0.022
B. 平卧 n) 1017Δ 3664 34.4 0.084 isd) 133 2683 13.5 0.025B. Lying n) 1017 Δ 3664 34.4 0.084 isd) 133 2683 13.5 0.025
C. ¾立 (《) 801ΔΔ 3520 46.4 0.090C. 3⁄4立(") 801 ΔΔ 3520 46.4 0.090
(irf) 125 2117 12.6 0.017(irf) 125 2117 12.6 0.017
D. 站立 (m) 787Δ 2902 37.3^ 0.086D. Standing ( m ) 787 Δ 2902 37.3^ 0.086
(sd) 128 2567 13.6 0.021 (sd) 128 2567 13.6 0.021
9£ϊ ·61 69 ·ε 6 ·ε 9£ϊ ·61 69 ·ε 6 ·ε
126 ·8ΐ 08Ι ·9 Ζ£Ζ ·0 νε ·6 126 ·8ΐ 08Ι ·9 Ζ£Ζ ·0 ν ε ·6
ίΌ8 ·9Ι ι · ISO Ό 6 - L O ·9Ι 7SSZ Ό L ·8 (ιβ) -x- t J 9S 'τ S6L Ό 110 ·0 Ζ ·9Τ Ό8 ·9Ι ι · ISO Ό 6 - LO ·9Ι 7 SSZ Ό L ·8 (ιβ) -x- t J 9S 'τ S6L Ό 110 ·0 Ζ ·9Τ
69Ζ -1 90£ Ί εεε ·ο 6 ·ιε («0 g ε Ι' '9 999 'τ 9L0 Ό s ·ζ\ 69Ζ -1 90£ Ί εεε ·ο 6 ·ιε («0 g ε Ι''9 999 'τ 9L0 Ό s ·ζ\
ίΌΐ · βη («") Ύ  Όΐ · · βη («") Ύ
: » dojfy 'ζ : » dojfy 'ζ
98S ·6 S99 ^ 9εε ·ο 9 ·ε【 (««) r?f a Ι6 ·6 ηβ ·τ 690 Ό ε  98S ·6 S99 ^ 9εε ·ο 9 ·ε【 (««) r?f a Ι6 ·6 ηβ ·τ 690 Ό ε
989 ·6 LIZ ·0 ΐ ·οι («*) Tff D 9 6 I ί-90 ·Ι L10 ·0 L · Ι  989 ·6 LIZ ·0 ΐ ·οι («*) Tff D 9 6 I ί-90 ·Ι L10 ·0 L · Ι
9LZ · εε·ΐ 9εε ·ο ΐ ·5£ («0 43 + ff ILL Τ 621 ·Ι 290 Ό L ΖΙ  9LZ · εε·ΐ 9εε ·ο ΐ ·5£ («0 43 + ff ILL 621 621 ·Ι 290 Ό L ΖΙ
ZLl 'τ 8S6 L2Z ·0 9 -9Ζ  ZLl 'τ 8S6 L2Z ·0 9 -9Ζ
•K上 Ί •K on Ί
HS/7S Hd/ld HS/7S Hd/ld
ND/13d 96ZZZ/Z.6 O 3. Propranolol! ND/13d 96ZZZ/Z.6 O 3. Propranolol!
A. 平卧 (《) 25.3 0.249 2.262 2.067 A. Flat (") 25.3 0.249 2.262 2.067
(sd) 9.3 0.053 1.987 1.775(sd) 9.3 0.053 1.987 1.775
B. 平卧 (m) 28.2 ' · · 0· 337 2.022 1.764 B. Lying (m) 28.2 ' · · 0· 337 2.022 1.764
14.2 0.012 1.952 1.516 14.2 0.012 1.952 1.516
C. 坫立 (IB) 10.1 0.235 6.124 8.691 C. Independence (IB) 10.1 0.235 6.124 8.691
(sd) 4.9 0.069 2.371 6.679 (sd) 4.9 0.069 2.371 6.679
D. 站立 n) ' · 16.1 ' · · 0· 330 ' ' 3.614 7.605 D. Standing n) ' · 16.1 ' · · 0· 330 ' ' 3.614 7.605
(sd) 7.8 0.019 2.114 7.734 (sd) 7.8 0.019 2.114 7.734
4. 以上 2和 3中 4. Above 2 and 3
的葯同时给:  The medicine is given at the same time:
A. 平卧 (《) 22.2 0.258 2.628 2.746  A. Flat (") 22.2 0.258 2.628 2.746
(.sd) 11.6 0.063 2.812 (.sd) 11.6 0.063 2.812
B. 平卧 (m) ' 29.3 " " * 0.338 1.864B. Flat (m) ' 29.3 " " * 0.338 1.864
(srf) 11.8 0.017 0.875 2.295(srf) 11.8 0.017 0.875 2.295
C. 站立 n) 10.3 0.246 5.561 7.337 C. Standing n) 10.3 0.246 5.561 7.337
(sd) 4.8 0.072 3.245 6.320 (sd) 4.8 0.072 3.245 6.320
D. 站立 (m) 13.1" ' ' 0.335 4.068 8.408 D. Standing (m) 13.1" ' ' 0.335 4.068 8.408
8.8 0.027 3.074 8.786 其中,敎据前的星号表示 A/B、C/D(自由呼吸段 /受控呼吸段)的比 4i:数据后的三角号分别表示第 2(给药阿托品)、第 3(給药心得宁) Ί 4(同时给药阿托品和心得宁)的状态与对照实验 K不给药)状 时的比 4 .,其中一个星号 " ' "表示 P< 0.05:两个星号 '·:' - "表示 I) 0.01:三 、星号" * -X "表示 P<0.001,它们表明有显著的特异 ■±: - 、三 /?]号 "Δ"表示 P<0.05:两个三 if]号"△△' 示 P 0.01: 三个三 /¾号"厶^ ',表示 P<0.001,它们表明有显著的特异性 n 参见表 2可以看到呼吸对心率谱的影响: 8.8 0.027 3.074 8.786 Where, the asterisk before the asterisk indicates the ratio of A/B, C/D (free breathing zone / controlled breathing zone) 4i: the triangle after the data indicates the second (administration of atropine), the first 3 (administration of Xinde Ning) Ί 4 (simultaneous administration of atropine and Xin De Ning) and the ratio of the control experiment K not administered) 4. One of the asterisks "'" indicates P < 0.05: two stars No. '·:' - "Expression I) 0.01: Three, asterisk "* -X" means P < 0.001, which indicates significant specificity. ±: -, three /?] "Δ" indicates P < 0.05: Two three if] numbers "△△" show P 0.01: Three three / number ¾ "Si ^ 'indicates P <0.001, which showed a significant specificity n can be seen in Table 2 Effect on Heart Rate Respiratory Spectrum:
呼吸对心率谱的影响:  The effect of breathing on the heart rate spectrum:
一般而言,高频分量的中心频率是与呼吸频率一致的。在实验中 'ί自由呼吸与受控呼吸(20次 /min,即 0.33Hz)对心率 ^的影响作了 比较。 在对照实验〗 中,受控呼吸使高频分量的中心頻率由 0.22〜 In general, the center frequency of the high frequency component is consistent with the respiratory rate. In the experiment, the effect of 'ί free breathing and controlled breathing (20 times / min, ie 0.33 Hz) on heart rate ^ was compared. In the control experiment, the controlled breathing causes the center frequency of the high frequency component to be 0.22~
0.24Hz移到 0.33Hz,与呼吸频率相同。 在卧位与立位状态,均 '使低 分量降低,高频分量增加,从而使 PL/PH分别由 2.0±1.1 变为0.24 Hz moved to 0.33 Hz, which is the same as the respiratory rate. In the lying position and the standing position, both lower the low component and increase the high frequency component, thereby changing the PL/PH from 2.0±1.1
1.2±1.0(卧位时),6.4±3.0变为 4.7士 2.5(立位时),且 P值均小 于 0.05,统计学上有显著差异。 1.2±1.0 (in the lying position), 6.4±3.0 became 4.7±2.5 (in the standing position), and the P value was less than 0.05, which was statistically significant.
这说明,进行受控呼吸,使呼吸运动力。强,刺激付交感兴奋,使付 ÷ .¾神经活性增加,交感神经活性相对减弱。这一结果与理论研究的 结果相同。  This means that controlled breathing is performed to make the breathing force. Strong, stimulating and sympathetic excitement, so that the 神经.3⁄4 increased neurological activity, sympathetic nerve activity is relatively weak. This result is the same as the theoretical study.
让我们再来看看药物对心率 1普的影响:  Let's take a look at the effects of drugs on heart rate 1
在药物条件下进行心率诸的研究,是为了确认心率谱的特 量 吋交 ,¾神经、付交感祌经系统活性的反映,以及这种分析方法对交 、什交感神经活动变化的敏感度。  The study of heart rate under drug conditions is to confirm the specificity of the heart rate spectrum, the reflection of the systemic activity of the 3⁄4 nerves, the sympathetic sympathetic system, and the sensitivity of this analysis method to changes in sympathetic and sympathetic activities.
从表 ] 和 我们可以看出,药物对于心率 i 的影响。  From the table] and we can see the effect of drugs on heart rate i.
在肌 ';主阿托品 1.0— L .5mg后,在卧位及立位状态下,均使高頻 分 有显著下降,分别由 27.0±11.9降到 20.6±13.4 (卧位时),由 I I. 1±5.3降至 7.3±3.1(立位时)。 这一结果与国外研究的动物实 中,用大剂量阿托品阻断付交感(迷走)神经,使高 分量消失或减 小的结 ¾一致 这说明心率谱中高频分量确实反映付交感(迷走)祌 的活动,可以作为临床上的一个指标。  In the muscle '; main atropine 1.0-L. 5mg, in the lying position and standing position, the high frequency scores decreased significantly, from 27.0 ± 11.9 to 20.6 ± 13.4 (in the lying position), by I I 1 ± 5.3 down to 7.3 ± 3.1 (in the standing position). This result is consistent with the animal studies in foreign countries, using large doses of atropine to block the sympathetic (vagus) nerves, causing the high component to disappear or decrease the agreement. This indicates that the high frequency components in the heart rate spectrum do reflect the sympathy (vagus). The activity can be used as an indicator in the clinic.
在口服 40mg心得宁后,从表 ] 中可以看出,由于心得宁对交感 神. 的阻断作用 ,使从卧位变为立位时,低频分量的增加相比对照实  After oral administration of 40mg of heart, it can be seen from the table that, due to the blocking effect of Xindeing on the sympathetic god, the increase of the low frequency component is compared with that of the contrast.
1 的增力。少 ,..吋照实验 1 中: 30.0 ± 10.6变为 .16.4 ± 11.9 ,心得宁 ' (3) :35. 1 ± 10.7变为 Ί 3.5 ± 9.7。因而得到这样一 ^提示:心 r吋于沐位的改变对交感神经的增强刺激有一定的阻断,但由于 ' ' ill ' 、 ίι· τ ,大部分被代谢掉 ,且个体差异较大,所 "统计上 异不 显著。 The power of 1 . Less, .. in the experiment 1: 30.0 ± 10.6 becomes .16.4 ± 11.9, Xin Deing ' (3): 35. 1 ± 10.7 becomes Ί 3.5 ± 9.7. Therefore, we get such a hint: the change of heart r吋 in the position of the sympathetic nerve has a certain block, but because '' ill ', ίι· τ, most of it is metabolized, and the individual difference is large, "Statistically different Significant.
从下面特例的情况看,也可以 明这种心率语的万法是吋自主 From the following special cases, it can also be seen that the law of this heart rate is autonomous.
(植物)神经劝能的一种有效的研究方法。 如在前 /L例做过心电图的 吋象中,其中 No. 4号,从其心电图中诊断出窦性心动过 ϋ,但仍属 于正常心电图范围。在对照实验( 1 )中,他的各特征值与 20例统计值 吋比如下表 3: (plant) An effective research method for neurosurgery. For example, in the previous /L cases of electrocardiogram, No. 4, sinus tachycardia was diagnosed from its electrocardiogram, but it still belongs to the normal ECG range. In the control experiment (1), his eigenvalues and 20 statistical values are shown in Table 3 below:
表 3 状 态 T(ms) V(mi' ) PL % ) LF(Hz)  Table 3 State T(ms) V(mi' ) PL % ) LF(Hz)
1016 4376 23. 3 0. 059  1016 4376 23. 3 0. 059
20例 mean 891 3992 30. 0 0. 099  20 cases mean 891 3992 30. 0 0. 099
sd 123 2431 10. 6 0. 019  Sd 123 2431 10. 6 0. 019
F. 站立 889 5239 40. 5 0. 065  F. Standing 889 5239 40. 5 0. 065
20例 mean 727 3400 46. 4 0. 083  20 cases mean 727 3400 46. 4 0. 083
sd 96 1506 11. 9 0. 015 表 3 (续) 状 态 HFCHz ) PL/PH SL/SH  Sd 96 1506 11. 9 0. 015 Table 3 (continued) Status HFCHz ) PL/PH SL/SH
E. 平卧 43. 5 0. 339 0. 535 0. 718  E. Lying 43. 5 0. 339 0. 535 0. 718
20例 mean 27. 0 0. 280 1. 388 1. 535  20 cases mean 27. 0 0. 280 1. 388 1. 535
sd 11. 9 0. 062 0. 987 1. 463  Sd 11. 9 0. 062 0. 987 1. 463
F. 站立 15. 9 0. 319 2. 555 4. 892  F. Standing 15. 9 0. 319 2. 555 4. 892
20例 mean 11. 1 0. 259 4. 999 9. 862  20 cases mean 11. 1 0. 259 4. 999 9. 862
sd 5. 3 0. 065 2. 220 6. 407 '人 iilL I') 20例统计值的吋比看,他的付交感神经活动明显 5¾于其他 人,而交感神经较弱。 ¾与县卖性心动过锾的心电图是相吻合的.从 而 "i正明这种方法是有效的和寻敏的。 Sd 5. 3 0. 065 2. 220 6. 407 'human iilL I') 20 cases of statistical value comparison, his sympathetic activity is obviously 53⁄4 other People, but the sympathetic nerves are weak. 3⁄4 is consistent with the electrocardiogram of the county-speaking tachycardia. Thus "i is clear that this method is effective and sensitized.
工业应用性 Industrial applicability
从目前对心率谱已有的研究看,临床上的某些病症,如心肌梗 、忮性充血性心力衰袞、糖尿病、高血压等;吋心率谱的改变远比^ 性心动过锾大得多,因此,通过对心率^的研究,为在临床上进行诊 断的分类、疾病的预测和疗效的观察,特别是评价心脏病患者的自主 神经系统,提供了一种有效的手段。  From the current research on heart rate spectrum, some clinical symptoms, such as myocardial infarction, spastic congestive heart failure, diabetes, high blood pressure, etc.; the heart rate spectrum changes far more than ^ tachycardia Therefore, through the study of heart rate ^, it provides an effective means for the classification of clinical diagnosis, the prediction of disease and the observation of curative effect, especially the evaluation of the autonomic nervous system of patients with heart disease.
虽然以上结合本发明的实施例以及实验对本发明进行了描述, 领城 ά ί?熟练技术人员应当能够理解到,在本发明的精神和范图之 内,可以做出各种修改和改变。  While the present invention has been described in connection with the embodiments of the present invention and the embodiments of the invention, it will be understood by those skilled in the art that various modifications and changes can be made within the spirit and scope of the invention.

Claims

权利要求 Rights request
I . 一种植物神经系统劝能测试糸统,其特征是包括: I. An autonomic nervous system persuasive test system characterized by:
便携式心电信号采集和存贮装置,用于在一预定时间内连续地 集和记录受试者处于一些不同状态以对交感神经系统和 /'或付交 感祌经糸统进行剌激时产生的心电信号;  Portable ECG signal acquisition and storage device for continuously collecting and recording a subject in a number of different states for a predetermined period of time to stimulate the sympathetic nervous system and/or the sympathetic system ECG signal;
含有一扬声器的语音单元,用于与所述预定时间相协调地指导 t: 者处于所述一些不同状态以荻得所需要的对交感神经糸统和 / A计交感神经系统的刺激;  a speech unit including a speaker for guiding the t: in the plurality of different states in coordination with the predetermined time to obtain the desired stimulation of the sympathetic nervous system and the /A sympathetic nervous system;
微计算机,用于对所述心电信号采集和存贮装置存贮的每一不 同状态时的心电信号相应分段地进行劝率谱分析以便得到交感神经 和付交感神经糸统对所受刺激的响应,进而 得它们兴备性状况的 论:其进一步包括:  a microcomputer for performing a perceptual spectrum analysis on the electrocardiographic signals in each different state stored by the ECG signal acquisition and storage device to obtain a sympathetic and sympathetic neural system Stimulating responses, and then their theory of adequacy: it further includes:
R波识別装置,用于对 EC 信号中的 R波进行识別,找出 R— R 期. 输出 R波序列信号:  R wave identification device for identifying the R wave in the EC signal and finding the R-R period. Outputting the R wave sequence signal:
分段和预处理装置,相应于所述一些不同状态对 R波序列信号 进 r分段和预处理,送出每一不同刺激状态下的分段的 R波/ f列信 The segmentation and pre-processing device segments and pre-processes the R-wave sequence signal corresponding to the different states, and sends the segmented R-wave/f-letter letter in each different stimulation state.
' 作为 X信号; ' as an X signal;
自回归(AR)模型错估计装置,用于找出包括模型糸数、白噪声 度和模型阶次 M的模型参数,对时域的所述 X信号进行 Z变 ¾ .以便对其进行频域的劝率 估计;  An autoregressive (AR) model error estimating device for finding model parameters including model parameters, white noise level, and model order M, and performing Z-change on the X signal in the time domain for frequency domain Persuasion rate estimate;
劝半 1 密度计算装置,用于根据所述模型参数计算 ^段心电信 号的劝率谱:以及  Persuading a half-density computing device for calculating the perceptual spectrum of the segmental heart signal based on the model parameters:
输出装置,用于打印输出心电信号的有关图形及其劝率 ^分析 ,比较报告。  The output device is used for printing and outputting the related signals of the electrocardiogram signal and its advisory rate, analysis and comparison report.
根据权利要求 ] 的糸统,其特征在于所述心电信号采集和存 : 进一步包括一个红外发射^装置,所述微计算机进一步与一 The system according to claim 2, wherein said ECG signal acquisition and storage further comprises an infrared emission device, said microcomputer further
'卜红外接收 II装置相连接,用以完成所述心电信号农集和存 e装置'Bu infrared receiving II device is connected to complete the ECG signal farming and storage device
' ! \ f-机之问的心电信号传输。 ' ! \ f- Machine's request for ECG signal transmission.
: \ . 根据权利要求 ] 的糸统,其中所述一些不同刺激状态分别为 Γ 下 em不同状志 ·' ^一段 Λ,在此段时间内, ±试者 于平卧休位 和自由呼"及状态,用以刺激付交感神经糸统和交惑神经糸统: 二段 1 '> ,在此役时间内 , X试者处于平卧休位和受控呼吸状态 ,用以 Ί激 ί十 Ζ感神经糸统:第三段 C,在此段时间内,受试者变为站立休位和 ]由呼吸状态,用以 Μ激交感祌经 统; 四段 ϋ ,在此段时间内, ; 者处于站立体位和受控呼吸状态,用以刺激交感和付交感神经 . ¾:其中受控呼吸的頻半高于自由呼吸的频率。 : \ . The system according to the claims, wherein the different stimulation states are respectively Γ下em different essays · ' ^ a period of time, during this period, ± tester in a supine position and free call " and state, to stimulate the payment of sympathetic nervous system and cross-talking neural system: two 1 '> During this time, the X tester was in a supine resting position and a controlled breathing state to stimulate the tenth sensory nervous system: the third segment C, during this time, the subject Become a standing position and] by breathing state, to stimulate the sympathetic 祌 ;; four paragraphs 在, during this time, are in standing position and controlled breathing state, used to stimulate sympathetic and sympathetic. 3⁄4: The frequency of controlled breathing is higher than the frequency of free breathing.
I . 根据权利要求 3的系统,其特征在于所述预定时间为 15分 ί ' ,其中所述 Λ段为 3分钟, Β段为 4分钟 , C段为 4分钟, D段为 !  The system according to claim 3, characterized in that said predetermined time is 15 minutes ί ' , wherein said Λ section is 3 minutes, Β section is 4 minutes, C section is 4 minutes, and D section is !
.— , . 根据权利要求 I的糸统,其特征在于所述 R波识 装置和分 m处理装置进一 包括用于求出心电信号一阶导数的低通差分装 'ΐ和 w于 出经低通 波的 ECG—阶导数的一阶低通^波装 ϋ,其.. , the system according to claim 1, characterized in that said R-wave identification device and said m-processing device further comprise low-pass differential devices '' and w' for extracting the first derivative of the electrocardiographic signal First-order low-pass wave-wave mounting of ECG-order derivatives of low-pass waves
,ϊι it分 'Ί为 ,ϊι it分 'Ί为
d(,t) = ECG(t)—ECG(t— 4) 和 (i) = (i-l)+ci(i)-ci(i-6) ;  d(,t) = ECG(t)—ECG(t—4) and (i) = (i-l)+ci(i)-ci(i-6) ;
·';)「述 κ波 m'l装置还包括心电图自学习装置,用于在吋心电 号进 Γ―役时 !'"]的自学习之后,对 f ( t )找出最大绝吋值 PK及两 1、 R -Rπ] ίνί, ,: i两 、 R - R间隔的平均值作为平均 R— R间 ίν¾的初始值:其 ' I' κ波 Η >;'1的装 采用的 R波识别阈值为: · ';) "The κ wave m'l device also includes an electrocardiogram self-learning device, which is used to find out the maximum absolute value of f ( t ) after the self-learning of the 吋 电 Γ Γ 役 役 役! The value PK and two 1, R - Rπ] ίνί, , : i, the average of the R - R interval as the initial value of ίν3⁄4 between the average R-R: its 'I' κ wave Η >; The R wave recognition threshold is:
Νίά :1 函数为:  Νίά :1 function is:
「0. 7 * //0(r.) +0. 3 » (0. 7 * PK(n) ) 0. 7 * ΡΚ 5 * Ho(n) ίί„('【 + 1 ) - : "0. 7 * // 0 (r.) +0. 3 » (0. 7 * PK(n) ) 0. 7 * ΡΚ 5 * Ho(n) ίί„('[ + 1 ) - :
0. 9 * ii„(n ) + 0. 1 * (0. 7 * PK'(n) 0. 7 * PK (n)>l. B *  0. 9 * ii„(n ) + 0. 1 * (0. 7 * PK'(n) 0. 7 * PK (n)>l. B *
(0. 8 ( ) + 0. 2 * (n) l (n -li>Q.5 ( (0. 8 ( ) + 0. 2 * (n) l (n -li>Q.5 (
KR W 其它 ϋ利要求 的装 ,其特 在于所述. 包括 W于根 据 R波识別装置的结果,做出 R— R间期的 R波序列信号曲线 ¾的 装置,并通过所述输出装置打印输出所述的信号曲线图。 KR W Other profit-making equipment, which is characterized by the above. Including W Yugen According to the result of the R-wave identification device, a device for generating an R-wave sequence signal curve of the R-R interval is outputted, and the signal graph is printed and output by the output device.
7. 根据权利要求 5的装置,其特征在于所述糸统还包括用于根 R波识別装置和分段预处理装置的结果,做出各段(八、 B、C、D、以 I E = A + B、F = C + D段和 R - E + F段)的 R波序列信号曲线图的 装置,并通过所述 C输出装置打印输出。  7. Apparatus according to claim 5 wherein said system further comprises results for root R wave identification means and segmentation preprocessing means, each segment (eight, B, C, D, IE) A device for the R-wave sequence signal graph of A + B, F = C + D segment and R - E + F segment, and printed out by the C output device.
8. 根据权利要求 5的束统,其特征在于所述 R波识別装置还进 一步包括一回检装置,当 R— R〉l . 8RRAV时,对该段再次进行 R波 识別,其回检阈值为:  8. The beam system according to claim 5, wherein said R wave identifying means further comprises a back detecting means, and when R - R > 1.8RRAV, R wave identification is performed again on the section, and back The threshold is:
H, (n ) = 0. 5 * H0 (n ) H, (n ) = 0. 5 * H 0 (n )
9. 根据权利要求 1和 5的系统,其特征在于所述自 Θ归( AR )模 型诸估计装置和劝率谱计算装置利用以下变换式进行 1 分析:  9. System according to claims 1 and 5, characterized in that said self-return (AR) model estimation means and persuasion spectrum calculation means perform the analysis using the following transformation:
Xn = Wn * h„ X n = W n * h„
其中 h,,为沖激响应; *为卷积,W,, 为白。桑声: h(n)  Where h, is the impulse response; * is the convolution, W, and is white. Sang Sheng: h(n)
H(Z) SX (Z) 则 Sx ( ) 其中 Ai?模型的表达式为: H(Z) S X (Z) then S x ( ) The expression of the Ai? model is:
M  M
X(n) = - ∑ a (K) X (n-K) + W (n)  X(n) = - ∑ a (K) X (n-K) + W (n)
K=l  K=l
变至頻域有:  Change to the frequency domain:
X(Z) M  X(Z) M
= H (Z) = 1 / ( 1+ ∑ a (K)  = H (Z) = 1 / ( 1+ ∑ a (K)
W (Z) K=l 其中所找到的模型糸数 a(fe)为: W (Z) K=l where the model parameter a(fe) found is:
所找到的白嗓声 1善密度为: The white singer found 1 good density is:
替换页 (细则第 26条) N0 = eMReplacement page (Article 26) N 0 = e M :
ί¾型阶次 Μ则依照信息论准则 Ί3⁄4 type order is based on information theory
取极小点时的 M值作为最佳阶次值,所述阶次 M在 11一 19之间逸 择;以及 The M value at the very small point is taken as the optimal order value, and the order M is selected between 11 and 19;
所述劝半语密度计算装置的劝率镨密度计算依下式进行:  The persuasion rate calculation of the persuasion semi-linguistic density computing device is performed according to the following formula:
M  M
S χ (f ) = o^t / 1+ ∑ aM K exp Η2 ί¾Α& ) |2 S χ (f ) = o^t / 1+ ∑ a MK exp Η2 ί3⁄4Α & ) | 2
K=l  K=l
其中 f 为频率 (¾),Z t为采样间隔。 Where f is the frequency (3⁄4) and Z t is the sampling interval.
10. 根据权利要求 7和 9的系统,其特征在于所述糸统还包括根 据自回归(AR)模型的变换估算结果,分别作出对应各段及全部 R波 序列信号和其劝率谱分析信号相对照的曲线图。  10. The system according to claims 7 and 9, characterized in that said system further comprises a transform estimation result according to an autoregressive (AR) model, respectively corresponding to each segment and all R wave sequence signals and their perceptual rate spectrum analysis signals Contrast graph.
11. 根据权利要求 10的糸统,其特征在于所述的微计算机所包 括的各所述装置由软件来完成。  11. A system according to claim 10, wherein each of said devices included in said microcomputer is implemented by software.
12. 一种检 '!植物神经糸统的劝能的方法,包括步骤: 12. A type of inspection! The method of persuasion of autonomic nervous system includes steps:
. 在一预定时间内,在对受试者交感神经糸统和 /或付交 ¾神经糸 ¾进行 mt的同时,采集和存贮受;式者的心电信号 E G:  Collecting and storing the ECG signal E G at the same time as the sympathetic nervous system and/or the 3⁄4 neural crests of the subject during a predetermined time period.
b. 对 ECG进行 R波识別,找出 R— R间期,給出 R波序列信号: c 依照步骤 a中对交感神经糸统和 /或付交感祌经 ..统进行刺 激的不同,分段截取所述 R波序列信号作为 X信号:  b. R wave identification of the ECG, find the R-R interval, and give the R wave sequence signal: c According to the difference in the stimulation of the sympathetic nervous system and/or the sympathetic sympathy in step a, Segmenting the R wave sequence signal as an X signal:
d. 利用自回归(AR)模型,对所述 X信号作 Z变换.以 吋其作 领城分析:  d. Using the autoregressive (AR) model, the Z-transformation of the X signal is performed.
f. 计算心电信号的劝率密度诸:  f. Calculate the persuasion rate of ECG signals:
g. 求出特征值,从而给出交感神经系统和付交感神经糸 ¾的定 量的分析结果。  g. Find the eigenvalues to give a quantitative analysis of the sympathetic nervous system and the sympathetic nerves.
13. 根据权利要求 12的方法,其特征在于所述步 ¾ a 中吋受;人 者交惑神经 统 "付交感祌经糸统进行 \激的 -7T式分为 "下 W Π 13. The method according to claim 12, characterized in that said step 3⁄4a is stunned; the person confuses the nervous system "paying sympathetic 祌 进行 进行 \ 激 -7 -7 -7 -7 -7 -7 -7 -7 -7 -7 -7 -7 -7 -7
I.受^者处于平卧休位并且自由呼吸状态八: I. The subject is in a supine position and free breathing state eight:
替换页 (细则第 26条) lii. 者变为站立 ί本位且进行自由呼吸的状态 C: 及 Replacement page (Article 26) Lii. The person becomes standing ί and is in a state of free breathing C: and
.v. ±试者 i 于站立沐泣且进行受控呼吸的状志 D:  .v. ±Tester i A crit who is standing and crying and performing controlled breathing D:
其中 ±控呼吸的頻率高于自由呼吸的频率„  Where ± the frequency of breathing is higher than the frequency of free breathing „
).1. 伥拔权利要求】3的方法,其特 在于所述預定时间为 I 5 分钟 ,其中状态 A ( i役 )持续 3分钟:状态 B ( ii )段持续 分钟;状 志 C(iii段)持续 分针:以及状态 D(iv段)持续 4 分  The method of claim 3, wherein the predetermined time is I 5 minutes, wherein state A (i) lasts for 3 minutes: state B (ii) continues for minutes; Segment) continuous minute hand: and state D (iv segment) lasts 4 minutes
1 . 根据权利要求 14的方法,其特征在于所述对交 ¾神经 统 和 ' 付交 ,¾神经 统的刺激包括向受 \k者施以特定的药物„ A method according to claim 14 wherein said stimulating of said anterior and gynecological stimuli comprises administering a specific drug to a subject.
K). 根据权利要求 15的方法,其特征在于所述特定的 物是阿 Jjta'a ( Atropine)和 /或心得宁 (Propranolol) c K). The method according to claim 15, characterized in that said specific substance is Ajj'a (Atropine) and/or Propranolol c
17. 根据权利要求】4的万法,其特 在于所述 ¾ 是采用 έ! 应判据进行的,进一步包括步骤:  17. The method of claim 4, wherein the 3⁄4 is performed using a έ! criterion, further comprising the steps of:
h i - 刊用公式 h i - publication formula
d(t) -ECG(t)-HCG(t-4)  d(t) -ECG(t)-HCG(t-4)
^出心乜信号一阶导数,·  ^The first derivative of the heart signal,
b2.利用公式  B2. Using formula
i'(t) -.: i'(t一 1 )+d(t)— d(t— )  i'(t) -.: i'(t - 1 )+d(t) - d(t- )
心乜 号 ό¾一阶导数进行低通滤波;  The heartbeat number ό3⁄4 first derivative is low pass filtered;
!)>.在一段时间内进行心电自学习,然后吋 f ( t )找出最大绝吋 i  !)>. Perform ECG self-learning for a period of time, then 吋 f ( t ) find the maximum absolute i
PK 7 两 i、 R— R间 1¾,后者的平均值作为平均 R— R间 i¾ RA V ^PK 7 two i, R-R between 13⁄4, the average of the latter as the average R-R between i3⁄4 RA V ^
j始位 ,其中 R波识 ¾')阈值为:  The j position, where R wave 3⁄4') threshold is:
11„(( ) - 0.7:': P  11„(( ) - 0.7:': P
b l. ;fi /f- Λ f- f ( t ) ,找出 P (n)―、、 Ho ( n ) ,并确 是 为 R波及 R  b l. ;fi /f- Λ f- f ( t ) , find P (n)―, , Ho ( n ), and indeed R wave and R
Αά') ii i .其中阔值自适应递归函数为:  Αά') ii i . The wide-value adaptive recursive function is:
* Ηο(η) * Ηο(η)
Ι.Γ RK.W ( ,) -H-R >0. S KKAV(n) Ι.Γ RK.W ( ,) -HR >0. S KKAV(n)
18. 根据权利要求 17的万法,其特征在于所述步^ t> ¾包括再 次识別 R波的回检步骤,其判定条件是,当 R-R> I . HRRAV时, 其进行 Θ检, Θ检阈值为: 18. The method according to claim 17, wherein said step comprises: a step of re-recognizing the R wave, wherein the condition is that when RR > I. HRRAV, the check is performed, Θ The threshold is:
H,(n) = 0.5 * H0(n)o H,(n) = 0.5 * H 0 (n) o
1 . 根据权利要求 12和 170 万法,其特征在于所述 d和 1' 作 ι 分析的变换公式 ∑ K为一一 :  1 . The method according to claims 12 and 1.7 million, characterized in that said d and 1' are transformed by ι analysis ∑ K is one by one:
1  1
ΧΜ=-ν π h„ Χ Μ =-ν π h„
其中: h„为沖激响应, *为卷 ^\, W„为白噪声: Where: h„ is the impulse response, * is the volume ^\, W„ is the white noise:
X二 n 1X two n 1
若 Z If Z
2  2
No\H ( " ') 其中 AW模型的函数为 n二  No\H ( " ') where the function of the AW model is n
lK n-K +WlK nK +W
i - Z 换 )s: i - Z for ) s:
i (z)  i (z)
H(Z) =  H(Z) =
w (z)  w (z)
— K  — K
aK  aK
其中樓 ¾ί束数 为; Among them, the number of buildings is 3⁄4ί;
· "- αΜ . I, 0.2 = Ow .;> ,… -— O-M · M: · "- α Μ . I, 0.2 = Ow .;> ,... - OM · M:
ΰ Α 度 No -CMΑ degree No - C M ;
其中所述 ^骤 d ¾ ίι括吋模 ¾阶次 M进行 ¾ u ^ ,即 M n 式  Wherein the ^ d 3⁄4 ί 吋 3 3⁄4 order M performs 3⁄4 u ^ , ie Mn
 3·
Λ I C Yi = + Λ IC Yi = +
Iv  Iv
- 31 - 替换页 (细则第 26条) 取其极小时的 M值为最诖阶次;所述 M值在 11一 j9之间逸择-. 20. 根据权利要求 18的方法,其特征在于所述步骤 f 中计尊 电信号劝率语密度的公式为 - 31 - Replacement page (Article 26) Taking the extremely small M value as the last order; the M value is between 11 and j9 - 20. The method according to claim 18, characterized in that the step f is used to estimate the electrical signal rate The formula for the density of words is
Sx(f) : o^t / aM Kexp (-j27XfK^t) S x (f) : o^t / a MK exp (-j27XfK^t)
其中 f 为频率(Hz),At为采样间隔。 Where f is the frequency (Hz) and At is the sampling interval.
21. 根据权利要求 12— 16的方法,其特征在于进一步包括吋多 例所述不同刺激方式的測试结果进行比轻和统计并給出比较 统 1十 结果的步骤。  21. A method according to any of claims 12-16, further comprising the step of comparing the test results of said different stimuli by a plurality of said stimuli and giving a comparative result.
22. 根据权利要求 12和 20的方法,其特征在于其中所述 & ' 步 由软件完成。  22. A method according to claims 12 and 20 wherein said & step is performed by software.
23. 根据权利要求 21的方法,其特征在于其中所述各 ' ¾由软 件完成。  23. The method of claim 21 wherein said each of said '3' is completed by software.
― 32 ― 32
替换页 (细则第 26条) Replacement page (Article 26)
PCT/CN1995/000097 1995-12-18 1995-12-18 System and method for testing the function of the autonomic nervous system WO1997022296A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/CN1995/000097 WO1997022296A1 (en) 1995-12-18 1995-12-18 System and method for testing the function of the autonomic nervous system
AU42519/96A AU4251996A (en) 1995-12-18 1995-12-18 System and method for testing the function of the autonomic nervous system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN1995/000097 WO1997022296A1 (en) 1995-12-18 1995-12-18 System and method for testing the function of the autonomic nervous system

Publications (1)

Publication Number Publication Date
WO1997022296A1 true WO1997022296A1 (en) 1997-06-26

Family

ID=4574947

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN1995/000097 WO1997022296A1 (en) 1995-12-18 1995-12-18 System and method for testing the function of the autonomic nervous system

Country Status (2)

Country Link
AU (1) AU4251996A (en)
WO (1) WO1997022296A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2504086C1 (en) * 2009-11-19 2014-01-10 Телефонактиеболагет Л М Эрикссон (Пабл) Sychronisation network configuration
CN109492707A (en) * 2018-11-28 2019-03-19 武汉轻工大学 Construction method, device, equipment and the storage medium of spectrum analysis model

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0256887A2 (en) * 1986-08-18 1988-02-24 Massachusetts Institute Of Technology A method of characterizing the dynamic response of the Autonomic Nervous System.
US5291400A (en) * 1992-04-09 1994-03-01 Spacelabs Medical, Inc. System for heart rate variability analysis
CN2164792Y (en) * 1993-06-04 1994-05-18 上海医科大学 Heart rate variation spectrum analyser
US5419338A (en) * 1994-02-22 1995-05-30 City Of Hope Autonomic nervous system testing by bi-variate spectral analysis of heart period and QT interval variability
US5437285A (en) * 1991-02-20 1995-08-01 Georgetown University Method and apparatus for prediction of sudden cardiac death by simultaneous assessment of autonomic function and cardiac electrical stability
WO1995028128A1 (en) * 1994-04-14 1995-10-26 Xiangsheng Wang A small-sized wearable system and method for heart protection
CN1113739A (en) * 1994-06-23 1995-12-27 王湘生 Function testing system for vegetative nervous system and its method

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0256887A2 (en) * 1986-08-18 1988-02-24 Massachusetts Institute Of Technology A method of characterizing the dynamic response of the Autonomic Nervous System.
US5437285A (en) * 1991-02-20 1995-08-01 Georgetown University Method and apparatus for prediction of sudden cardiac death by simultaneous assessment of autonomic function and cardiac electrical stability
US5291400A (en) * 1992-04-09 1994-03-01 Spacelabs Medical, Inc. System for heart rate variability analysis
CN2164792Y (en) * 1993-06-04 1994-05-18 上海医科大学 Heart rate variation spectrum analyser
US5419338A (en) * 1994-02-22 1995-05-30 City Of Hope Autonomic nervous system testing by bi-variate spectral analysis of heart period and QT interval variability
WO1995028128A1 (en) * 1994-04-14 1995-10-26 Xiangsheng Wang A small-sized wearable system and method for heart protection
CN1113739A (en) * 1994-06-23 1995-12-27 王湘生 Function testing system for vegetative nervous system and its method

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2504086C1 (en) * 2009-11-19 2014-01-10 Телефонактиеболагет Л М Эрикссон (Пабл) Sychronisation network configuration
CN109492707A (en) * 2018-11-28 2019-03-19 武汉轻工大学 Construction method, device, equipment and the storage medium of spectrum analysis model
CN109492707B (en) * 2018-11-28 2020-10-23 武汉轻工大学 Method, device and equipment for constructing spectral analysis model and storage medium

Also Published As

Publication number Publication date
AU4251996A (en) 1997-07-14

Similar Documents

Publication Publication Date Title
CN105147248B (en) Depression assessment system and its appraisal procedure based on physiologic information
Chan et al. Wavelet distance measure for person identification using electrocardiograms
CN104173043B (en) Electrocardiogram (ECG) data analysis method suitable for mobile platform
EP1495715B1 (en) A method and apparatus based on combination of three phsysiological parameters for assessment of analgesia during anesthesia or sedation
US7862515B2 (en) Apparatus for detecting sleep apnea using electrocardiogram signals
US7225013B2 (en) Adaptive prediction of changes of physiological/pathological states using processing of biomedical signals
US8211015B2 (en) Obstetric analgesia system
US8290577B2 (en) Methods and apparatus for enhanced fiducial point determination and non-invasive hemodynamic parameter determination
US20140180036A1 (en) Device and method for predicting and preventing obstructive sleep apnea (osa) episodes
EP2085025B1 (en) Autonomic nerve activity measuring apparatus and autonomic nerve activity measuring method
CN104321013A (en) Method and apparatus for providing a visual representation of sleep quality based on ECG signals
EP1639497B1 (en) Method and apparatus for extracting causal information from a chaotic time series
US20190167227A1 (en) System and Method for Monitoring Airflow in a Subject&#39;s Airway with Ultrasound
US8352020B2 (en) Method for processing a series of cardiac rhythm signals (RR) and the use thereof for analysing a cardiac rhythm variability, in particular for assessing a patient&#39;s pain or stress
CN103892812A (en) Matching degree analysis technology
EP3518757A1 (en) Monitoring of biosignals, in particular electrocardiograms
WO2017027232A1 (en) System and method for sympathetic and parasympathetic activity monitoring by heartbeat
US20030135126A1 (en) Detector for measuring electrocardiogram, pulse and voice sound at the same time
US7549959B2 (en) Stimulation arrangement for measurement of physiological signal reactivity
DE102009033829A1 (en) Method for monitoring heart, circulation and respiration of child, involves calculating correlated ECG waveforms, heart rate curves and respiratory rhythm courses from evaluated Doppler information by module of hybrid system
Reilly et al. Respiratory sinus arrhythmia during speech production
US20200107989A1 (en) System and method of noninvasive blood flow measurement during cardiopulmonary resuscitation using signal gating
WO1997022296A1 (en) System and method for testing the function of the autonomic nervous system
EP4327743A1 (en) Sleeping state estimation system
JP2006130121A (en) Sentiment recognition method based on biological information

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AM AT AU BB BG BR BY CA CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97522393

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642